Skip to content
Triangle logo TriangleGet started
← Back to this collection

LABELS · 04bedd16-44e8-4761-bb65-d4678c4013af

HYRIMOZ

Open original source → · Download preserved record

Preserved label snapshot, not confirmation of a current approved indication. Approval/withdrawal status must be checked for the exact disease, setting and regimen.

Label effective date
2025-10-17
Captured
2026-09-09T23:37:39.774134+00:00
Current indication reconciliation
Not reconciled
Boxed warning in this label
  1. WARNING: SERIOUS INFECTIONS and MALIGNANCY SERIOUS INFECTIONS Patients treated with adalimumab products, including HYRIMOZ, are at increased risk for developing serious infections that may lead to hospitalization or death [see Warnings and Precautions ( 5.1 )] . Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids. Discontinue HYRIMOZ if a patient develops a serious infection or sepsis. Reported infections include: • Active tuberculosis (TB), including reactivation of latent TB. Patients with TB have frequently presented with disseminated or extrapulmonary disease. Test patients for latent TB before HYRIMOZ use and during therapy. Initiate treatment for latent TB prior to HYRIMOZ use. • Invasive fungal infections, including histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, and pneumocystosis. Patients with histoplasmosis or other invasive fungal infections may present with disseminated, rather than localized, disease. Antigen and antibody testing for histoplasmosis may be negative in some patients with active infection. Consider empiric anti-fungal therapy in patients at risk for invasive fungal infections who develop severe systemic illness. • Bacterial, viral and other infections due to opportunistic pathogens, including Legionella and Listeria. Carefully consider the risks and benefits of treatment with HYRIMOZ prior to initiating therapy in patients with chronic or recurrent infection. Monitor patients closely for the development of signs and symptoms of infection during and after treatment with HYRIMOZ, including the possible development of TB in patients who tested negative for latent TB infection prior to initiating therapy [see Warnings and Precautions ( 5.1 ) and Adverse Reactions ( 6.1 )]. MALIGNANCY Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers including adalimumab products [ see Warnings and Precautions ( 5.2 ) ]. Post-marketing cases of hepatosplenic T-cell lymphoma (HSTCL), a rare type of T-cell lymphoma, have been reported in patients treated with TNF blockers including adalimumab products. These cases have had a very aggressive disease course and have been fatal. The majority of reported TNF blocker cases have occurred in patients with Crohn's disease or ulcerative colitis and the majority were in adolescent and young adult males. Almost all these patients had received treatment with azathioprine or 6-mercaptopurine (6–MP) concomitantly with a TNF blocker at or prior to diagnosis. It is uncertain whether the occurrence of HSTCL is related to use of a TNF blocker or a TNF blocker in combination with these other immunosuppressants [see Warnings and Precautions ( 5.2 )]. WARNING: SERIOUS INFECTIONS and MALIGNANCY See full prescribing information for complete boxed warning . SERIOUS INFECTIONS ( 5.1 , 6.1 ): • Increased risk of serious infections leading to hospitalization or death, including tuberculosis (TB), bacterial sepsis, invasive fungal infections (such as histoplasmosis), and infections due to other opportunistic pathogens. • Discontinue HYRIMOZ if a patient develops a serious infection or sepsis during treatment. • Perform test for latent TB; if positive, start treatment for TB prior to starting HYRIMOZ. • Monitor all patients for active TB during treatment, even if initial latent TB test is negative. MALIGNANCY ( 5.2 ): • Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers including adalimumab products. • Post-marketing cases of hepatosplenic T-cell lymphoma (HSTCL), a rare type of T-cell lymphoma, have occurred in adolescent and young adults with inflammatory bowel disease treated with TNF blockers including adalimumab products.

Indications and usage: exact source text

  1. 1 INDICATIONS AND USAGE HYRIMOZ is a tumor necrosis factor (TNF)-blocker indicated for: • Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. (1.1) • Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. (1.2) • Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis. (1.3) • Reducing signs and symptoms in adult patients with active ankylosing spondylitis. (1.4) • Treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older. (1.5) • Treatment of moderately to severely active ulcerative colitis in adult patients. ( 1.6 ) Limitations of Use : Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers. • Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. ( 1.7 ) • Treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older. ( 1.8 ) • Treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older. ( 1.9 ) 1.1 Rheumatoid Arthritis HYRIMOZ is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. HYRIMOZ can be used alone or in combination with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs). 1.2 Juvenile Idiopathic Arthritis HYRIMOZ is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. HYRIMOZ can be used alone or in combination with methotrexate. 1.3 Psoriatic Arthritis HYRIMOZ is indicated for reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis. HYRIMOZ can be used alone or in combination with non-biologic DMARDs. 1.4 Ankylosing Spondylitis HYRIMOZ is indicated for reducing signs and symptoms in adult patients with active ankylosing spondylitis. 1.5 Crohn’s Disease HYRIMOZ is indicated for the treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older. 1.6 Ulcerative Colitis HYRIMOZ is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: The effectiveness of adalimumab products has not been established in patients who have lost response to or were intolerant to TNF-blockers [see Clinical Studies (14.7) ] . 1.7 Plaque Psoriasis HYRIMOZ is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. HYRIMOZ should only be administered to patients who will be closely monitored and have regular follow-up visits with a physician [see Warnings and Precautions (5) ] . 1.8 Hidradenitis Suppurativa HYRIMOZ is indicated for the treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older. 1.9 Uveitis HYRIMOZ is indicated for the treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.
  2. 1.6 Ulcerative Colitis HYRIMOZ is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: The effectiveness of adalimumab products has not been established in patients who have lost response to or were intolerant to TNF-blockers [see Clinical Studies (14.7) ] .
  3. 1.7 Plaque Psoriasis HYRIMOZ is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. HYRIMOZ should only be administered to patients who will be closely monitored and have regular follow-up visits with a physician [see Warnings and Precautions (5) ] .
Full extracted label fields
application numbers
  1. BLA761071
boxed warning exact
  1. WARNING: SERIOUS INFECTIONS and MALIGNANCY SERIOUS INFECTIONS Patients treated with adalimumab products, including HYRIMOZ, are at increased risk for developing serious infections that may lead to hospitalization or death [see Warnings and Precautions ( 5.1 )] . Most patients who developed these infections were taking concomitant immunosuppressants such as methotrexate or corticosteroids. Discontinue HYRIMOZ if a patient develops a serious infection or sepsis. Reported infections include: • Active tuberculosis (TB), including reactivation of latent TB. Patients with TB have frequently presented with disseminated or extrapulmonary disease. Test patients for latent TB before HYRIMOZ use and during therapy. Initiate treatment for latent TB prior to HYRIMOZ use. • Invasive fungal infections, including histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, and pneumocystosis. Patients with histoplasmosis or other invasive fungal infections may present with disseminated, rather than localized, disease. Antigen and antibody testing for histoplasmosis may be negative in some patients with active infection. Consider empiric anti-fungal therapy in patients at risk for invasive fungal infections who develop severe systemic illness. • Bacterial, viral and other infections due to opportunistic pathogens, including Legionella and Listeria. Carefully consider the risks and benefits of treatment with HYRIMOZ prior to initiating therapy in patients with chronic or recurrent infection. Monitor patients closely for the development of signs and symptoms of infection during and after treatment with HYRIMOZ, including the possible development of TB in patients who tested negative for latent TB infection prior to initiating therapy [see Warnings and Precautions ( 5.1 ) and Adverse Reactions ( 6.1 )]. MALIGNANCY Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers including adalimumab products [ see Warnings and Precautions ( 5.2 ) ]. Post-marketing cases of hepatosplenic T-cell lymphoma (HSTCL), a rare type of T-cell lymphoma, have been reported in patients treated with TNF blockers including adalimumab products. These cases have had a very aggressive disease course and have been fatal. The majority of reported TNF blocker cases have occurred in patients with Crohn's disease or ulcerative colitis and the majority were in adolescent and young adult males. Almost all these patients had received treatment with azathioprine or 6-mercaptopurine (6–MP) concomitantly with a TNF blocker at or prior to diagnosis. It is uncertain whether the occurrence of HSTCL is related to use of a TNF blocker or a TNF blocker in combination with these other immunosuppressants [see Warnings and Precautions ( 5.2 )]. WARNING: SERIOUS INFECTIONS and MALIGNANCY See full prescribing information for complete boxed warning . SERIOUS INFECTIONS ( 5.1 , 6.1 ): • Increased risk of serious infections leading to hospitalization or death, including tuberculosis (TB), bacterial sepsis, invasive fungal infections (such as histoplasmosis), and infections due to other opportunistic pathogens. • Discontinue HYRIMOZ if a patient develops a serious infection or sepsis during treatment. • Perform test for latent TB; if positive, start treatment for TB prior to starting HYRIMOZ. • Monitor all patients for active TB during treatment, even if initial latent TB test is negative. MALIGNANCY ( 5.2 ): • Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers including adalimumab products. • Post-marketing cases of hepatosplenic T-cell lymphoma (HSTCL), a rare type of T-cell lymphoma, have occurred in adolescent and young adults with inflammatory bowel disease treated with TNF blockers including adalimumab products.
brand names
  1. HYRIMOZ
current indication status
not_reconciled
dailymed set url
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e303a4a-980b-4f2a-9d03-786928758637
generic names
  1. ADALIMUMAB-ADAZ
id
04bedd16-44e8-4761-bb65-d4678c4013af
indications and usage exact
  1. 1 INDICATIONS AND USAGE HYRIMOZ is a tumor necrosis factor (TNF)-blocker indicated for: • Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. (1.1) • Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. (1.2) • Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis. (1.3) • Reducing signs and symptoms in adult patients with active ankylosing spondylitis. (1.4) • Treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older. (1.5) • Treatment of moderately to severely active ulcerative colitis in adult patients. ( 1.6 ) Limitations of Use : Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers. • Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. ( 1.7 ) • Treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older. ( 1.8 ) • Treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older. ( 1.9 ) 1.1 Rheumatoid Arthritis HYRIMOZ is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. HYRIMOZ can be used alone or in combination with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs). 1.2 Juvenile Idiopathic Arthritis HYRIMOZ is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. HYRIMOZ can be used alone or in combination with methotrexate. 1.3 Psoriatic Arthritis HYRIMOZ is indicated for reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis. HYRIMOZ can be used alone or in combination with non-biologic DMARDs. 1.4 Ankylosing Spondylitis HYRIMOZ is indicated for reducing signs and symptoms in adult patients with active ankylosing spondylitis. 1.5 Crohn’s Disease HYRIMOZ is indicated for the treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older. 1.6 Ulcerative Colitis HYRIMOZ is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: The effectiveness of adalimumab products has not been established in patients who have lost response to or were intolerant to TNF-blockers [see Clinical Studies (14.7) ] . 1.7 Plaque Psoriasis HYRIMOZ is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. HYRIMOZ should only be administered to patients who will be closely monitored and have regular follow-up visits with a physician [see Warnings and Precautions (5) ] . 1.8 Hidradenitis Suppurativa HYRIMOZ is indicated for the treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older. 1.9 Uveitis HYRIMOZ is indicated for the treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.
  2. 1.6 Ulcerative Colitis HYRIMOZ is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: The effectiveness of adalimumab products has not been established in patients who have lost response to or were intolerant to TNF-blockers [see Clinical Studies (14.7) ] .
  3. 1.7 Plaque Psoriasis HYRIMOZ is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. HYRIMOZ should only be administered to patients who will be closely monitored and have regular follow-up visits with a physician [see Warnings and Precautions (5) ] .
indications and usage tables exact
    is original packager
    1. true
    manufacturer names
    1. Cordavis Limited
    matched search terms
    1. tumor
    package ndcs
    1. 83457-100-01
    2. 83457-101-01
    3. 83457-102-01
    4. 83457-103-01
    5. 83457-108-01
    6. 83457-107-01
    7. 83457-113-01
    8. 83457-112-01
    product ndcs
    1. 83457-100
    2. 83457-101
    3. 83457-102
    4. 83457-103
    5. 83457-108
    6. 83457-107
    7. 83457-113
    8. 83457-112
    product types
    1. HUMAN PRESCRIPTION DRUG
    recent major changes exact
    1. Indications and Usage, Hidradenitis Suppurativa ( 1.8 ) 10/2025 Indications and Usage, Uveitis ( 1.9 ) 10/2025 Dosage and Administration, Uveitis ( 2.3 ) 10/2025 Dosage and Administration, Hidradenitis Suppurativa ( 2.7 ) 10/2025 Warnings and Precautions, Autoimmunity ( 5.9 ) 10/2025
    record type
    complete_spl_indications_section_candidate
    routes
    1. SUBCUTANEOUS
    rxcuis
    1. 2641653
    2. 2641654
    3. 2641655
    4. 2641658
    5. 2641660
    6. 2641661
    7. 2641662
    8. 2641663
    9. 2641664
    10. 2641665
    11. 2641670
    12. 2641671
    source batch
    file
    /private/tmp/cancer-full-research/indications/raw/labels-00000.json
    meta
    disclaimer
    Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
    last updated
    2026-09-09
    results
    limit
    100
    skip
    0
    total
    830
    sha256
    0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
    url
    https://api.fda.gov/drug/label.json?search=%28indications_and_usage%3Acancer+OR+indications_and_usage%3Acarcinoma+OR+indications_and_usage%3Acarcinomas+OR+indications_and_usage%3Alymphoma+OR+indications_and_usage%3Alymphomas+OR+indications_and_usage%3Aleukemia+OR+indications_and_usage%3Aleukaemia+OR+indications_and_usage%3Asarcoma+OR+indications_and_usage%3Asarcomas+OR+indications_and_usage%3Amelanoma+OR+indications_and_usage%3Amyeloma+OR+indications_and_usage%3Atumor+OR+indications_and_usage%3Atumors+OR+indications_and_usage%3Atumour+OR+indications_and_usage%3Atumours+OR+indications_and_usage%3Aneoplasm+OR+indications_and_usage%3Aneoplasms+OR+indications_and_usage%3Amalignant+OR+indications_and_usage%3Amalignancy+OR+indications_and_usage%3Amyelodysplastic+OR+indications_and_usage%3Amyelofibrosis+OR+indications_and_usage%3Amastocytosis+OR+indications_and_usage%3Aglioma+OR+indications_and_usage%3Aglioblastoma+OR+indications_and_usage%3Aneuroblastoma+OR+indications_and_usage%3Aretinoblastoma+OR+indications_and_usage%3Apheochromocytoma+OR+indications_and_usage%3Aparaganglioma+OR+indications_and_usage%3Amyeloproliferative+OR+indications_and_usage%3Awaldenstrom+OR+indications_and_usage%3Apolycythemia+OR+indications_and_usage%3Athrombocythemia+OR+indications_and_usage%3Adesmoid+OR+indications_and_usage%3Aneurofibromatosis+OR+indications_and_usage%3Ahistiocytosis%29+AND+%28openfda.application_number%3ANDA%2A+OR+openfda.application_number%3ABLA%2A%29&limit=100&skip=0&sort=id%3Aasc
    source url
    https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
    spl effective date
    2025-10-17
    spl effective time
    20251017
    spl set id
    3e303a4a-980b-4f2a-9d03-786928758637
    spl version
    7
    substance names
    1. ADALIMUMAB
    uniis
    1. FYS6T7F842
    verification flags
    1. oncology_keyword_candidate_not_clinically_classified
    2. spl_text_not_verified_identical_to_latest_approved_label
    3. individual_indications_not_split_or_reconciled
    4. fda_label_posted_after_spl_effective_date_requires_version_review
    Drugs@FDA application source records
    1. application number
      BLA761071
      payload
      all indexed label documents
      1. Appl No
        761071
        Application Docs Date
        2018-10-31 00:00:00
        Application Docs ID
        56201
        Application Docs Title
        0
        Application Docs Type ID
        2
        Submission No
        1
        Submission Type
        ORIG
      2. Appl No
        761071
        Application Docs Date
        2021-02-26 00:00:00
        Application Docs ID
        66408
        Application Docs Title
        0
        Application Docs Type ID
        2
        Submission No
        1
        Submission Type
        SUPPL
      3. Appl No
        761071
        Application Docs Date
        2022-03-29 00:00:00
        Application Docs ID
        70646
        Application Docs Title
        0
        Application Docs Type ID
        2
        Submission No
        11
        Submission Type
        SUPPL
      4. Appl No
        761071
        Application Docs Date
        2022-07-20 00:00:00
        Application Docs ID
        71611
        Application Docs Title
        0
        Application Docs Type ID
        2
        Submission No
        12
        Submission Type
        SUPPL
      5. Appl No
        761071
        Application Docs Date
        2022-07-20 00:00:00
        Application Docs ID
        71612
        Application Docs Title
        0
        Application Docs Type ID
        2
        Submission No
        10
        Submission Type
        SUPPL
      6. Appl No
        761071
        Application Docs Date
        2023-03-27 00:00:00
        Application Docs ID
        73866
        Application Docs Title
        0
        Application Docs Type ID
        2
        Submission No
        14
        Submission Type
        SUPPL
      7. Appl No
        761071
        Application Docs Date
        2023-04-17 00:00:00
        Application Docs ID
        74005
        Application Docs Title
        0
        Application Docs Type ID
        2
        Submission No
        15
        Submission Type
        SUPPL
      8. Appl No
        761071
        Application Docs Date
        2023-09-13 00:00:00
        Application Docs ID
        75442
        Application Docs Title
        0
        Application Docs Type ID
        2
        Submission No
        16
        Submission Type
        SUPPL
      9. Appl No
        761071
        Application Docs Date
        2024-04-09 00:00:00
        Application Docs ID
        78097
        Application Docs Title
        0
        Application Docs Type ID
        2
        Submission No
        19
        Submission Type
        SUPPL
      10. Appl No
        761071
        Application Docs Date
        2024-06-13 00:00:00
        Application Docs ID
        78795
        Application Docs Title
        0
        Application Docs Type ID
        2
        Submission No
        21
        Submission Type
        SUPPL
      11. Appl No
        761071
        Application Docs Date
        2025-05-20 00:00:00
        Application Docs ID
        82231
        Application Docs Title
        0
        Application Docs Type ID
        2
        Submission No
        22
        Submission Type
        SUPPL
      12. Appl No
        761071
        Application Docs Date
        2025-07-30 00:00:00
        Application Docs ID
        82990
        Application Docs Title
        0
        Application Docs Type ID
        2
        Submission No
        24
        Submission Type
        SUPPL
      all submission records
      1. Appl No
        761071
        Review Priority
        Submission Class Code ID
        28
        Submission No
        31
        Submission Status
        AP
        Submission Status Date
        2025-10-16 00:00:00
        Submission Type
        SUPPL
        Submissions Public Notes
      2. Appl No
        761071
        Review Priority
        STANDARD
        Submission Class Code ID
        3
        Submission No
        24
        Submission Status
        AP
        Submission Status Date
        2025-07-29 00:00:00
        Submission Type
        SUPPL
        Submissions Public Notes
      3. Appl No
        761071
        Review Priority
        N/A
        Submission Class Code ID
        6
        Submission No
        22
        Submission Status
        AP
        Submission Status Date
        2025-05-20 00:00:00
        Submission Type
        SUPPL
        Submissions Public Notes
      4. Appl No
        761071
        Review Priority
        STANDARD
        Submission Class Code ID
        3
        Submission No
        21
        Submission Status
        AP
        Submission Status Date
        2024-06-12 00:00:00
        Submission Type
        SUPPL
        Submissions Public Notes
      5. Appl No
        761071
        Review Priority
        UNKNOWN
        Submission Class Code ID
        1
        Submission No
        19
        Submission Status
        AP
        Submission Status Date
        2024-04-05 00:00:00
        Submission Type
        SUPPL
        Submissions Public Notes
      6. Appl No
        761071
        Review Priority
        N/A
        Submission Class Code ID
        1
        Submission No
        16
        Submission Status
        AP
        Submission Status Date
        2023-09-08 00:00:00
        Submission Type
        SUPPL
        Submissions Public Notes
      7. Appl No
        761071
        Review Priority
        STANDARD
        Submission Class Code ID
        19
        Submission No
        15
        Submission Status
        AP
        Submission Status Date
        2023-04-14 00:00:00
        Submission Type
        SUPPL
        Submissions Public Notes
      8. Appl No
        761071
        Review Priority
        STANDARD
        Submission Class Code ID
        2
        Submission No
        14
        Submission Status
        AP
        Submission Status Date
        2023-03-20 00:00:00
        Submission Type
        SUPPL
        Submissions Public Notes
      9. Appl No
        761071
        Review Priority
        STANDARD
        Submission Class Code ID
        2
        Submission No
        12
        Submission Status
        AP
        Submission Status Date
        2022-07-18 00:00:00
        Submission Type
        SUPPL
        Submissions Public Notes
      10. Appl No
        761071
        Review Priority
        N/A
        Submission Class Code ID
        4
        Submission No
        11
        Submission Status
        AP
        Submission Status Date
        2022-03-28 00:00:00
        Submission Type
        SUPPL
        Submissions Public Notes
      11. Appl No
        761071
        Review Priority
        STANDARD
        Submission Class Code ID
        2
        Submission No
        10
        Submission Status
        AP
        Submission Status Date
        2022-07-18 00:00:00
        Submission Type
        SUPPL
        Submissions Public Notes
      12. Appl No
        761071
        Review Priority
        STANDARD
        Submission Class Code ID
        3
        Submission No
        1
        Submission Status
        AP
        Submission Status Date
        2021-02-24 00:00:00
        Submission Type
        SUPPL
        Submissions Public Notes
      application number
      BLA761071
      approval interpretation
      Application linkage and approved submission are not indication-level current approval verification
      current indication status
      not_reconciled
      has approved submission record
      true
      latest approved submission date
      2025-10-16
      latest label selection rule
      max FDA ApplicationDocsDate, including all ties; posting date is not approval date and latest indexed document may be incomplete
      latest posted label documents
      1. Appl No
        761071
        Application Docs Date
        2025-10-21 00:00:00
        Application Docs ID
        83834
        Application Docs Title
        0
        Application Docs Type ID
        2
        Submission No
        31
        Submission Type
        SUPPL
      official application record
      Appl No
      761071
      Appl Public Notes
      Appl Type
      BLA
      Sponsor Name
      SANDOZ INC
      openfda application present
      true
      products
      1. Active Ingredient
        ADALIMUMAB-ADAZ
        Appl No
        761071
        Drug Name
        HYRIMOZ
        Form
        INJECTABLE;INJECTION
        Product No
        001
        Reference Drug
        0
        Reference Standard
        0
        Strength
        40MG/0.8ML
        marketing status
        1. Prescription

    Source passages and status connections

    Passage classifications are automated and are not treatment recommendations. Connections apply only to their recorded indication scope.

    Passage 1 · indication intro context
    application numbers
    1. BLA761071
    brand names
    1. HYRIMOZ
    classification reasons
    1. explicit_positive_indication_predicate
    2. tumor_or_malignant_hematology_words_in_positive_statement
    3. incomplete_colon_led_indication_intro
    clinical review status
    pending
    content role
    indication_intro_context
    context span
    end
    287
    end exclusive
    true
    exact text
    1 INDICATIONS AND USAGE HYRIMOZ is a tumor necrosis factor (TNF)-blocker indicated for: • Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active
    label id
    04bedd16-44e8-4761-bb65-d4678c4013af
    offset unit
    unicode_code_points
    source array index
    0
    source field
    indications_and_usage_exact
    source text sha256
    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
    start
    0
    current approval status
    not_reconciled
    duplicate text group
    dup-f11fb94faacfe35e9575
    extraction review status
    automated_candidate_pending_source_review
    generic names
    1. ADALIMUMAB-ADAZ
    id
    ind-span-50f403ef25c803a2c0d8
    label id
    04bedd16-44e8-4761-bb65-d4678c4013af
    positive predicate support span
    end
    82
    end exclusive
    true
    exact text
    is a tumor necrosis factor (TNF)-blocker indicated
    label id
    04bedd16-44e8-4761-bb65-d4678c4013af
    offset unit
    unicode_code_points
    source array index
    0
    source field
    indications_and_usage_exact
    source text sha256
    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
    start
    32
    qualifier mentions
      regulatory links
        schema version
        0.1.0
        source batch sha256
        0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
        source defined aliases
          source span
          end
          87
          end exclusive
          true
          exact text
          1 INDICATIONS AND USAGE HYRIMOZ is a tumor necrosis factor (TNF)-blocker indicated for:
          label id
          04bedd16-44e8-4761-bb65-d4678c4013af
          offset unit
          unicode_code_points
          source array index
          0
          source field
          indications_and_usage_exact
          source text sha256
          e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
          start
          0
          source url
          https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
          spl effective date
          2025-10-17
          spl set id
          3e303a4a-980b-4f2a-9d03-786928758637
          spl version
          7
          structured fields status
          not_extracted_no_values_inferred_from_mentions
          structured indication
          age
          Source null
          approval pathway
          Source null
          biomarker and test
          Source null
          disease stage
          Source null
          limitations
          Source null
          line
          Source null
          prior therapy
          Source null
          regimen
          Source null
          tumor histology
          Source null
          use intent
          not_applicable
          Passage 2 · positive indication candidate
          application numbers
          1. BLA761071
          brand names
          1. HYRIMOZ
          classification reasons
          1. inherited_predicate_from_same_label_section_requires_review
          2. no_tumor_directed_keyword_in_positive_statement
          clinical review status
          pending
          content role
          positive_indication_candidate
          context span
          end
          508
          end exclusive
          true
          exact text
          1 INDICATIONS AND USAGE HYRIMOZ is a tumor necrosis factor (TNF)-blocker indicated for: • Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. (1.1) • Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. (1.2) • Reducing signs and symptoms, inhibiting
          label id
          04bedd16-44e8-4761-bb65-d4678c4013af
          offset unit
          unicode_code_points
          source array index
          0
          source field
          indications_and_usage_exact
          source text sha256
          e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
          start
          0
          current approval status
          not_reconciled
          duplicate text group
          dup-c9a32278aa49da75eaf7
          extraction review status
          automated_candidate_pending_source_review
          generic names
          1. ADALIMUMAB-ADAZ
          id
          ind-span-9c9400569da3e92a89f2
          label id
          04bedd16-44e8-4761-bb65-d4678c4013af
          positive predicate support span
          end
          82
          end exclusive
          true
          exact text
          is a tumor necrosis factor (TNF)-blocker indicated
          label id
          04bedd16-44e8-4761-bb65-d4678c4013af
          offset unit
          unicode_code_points
          source array index
          0
          source field
          indications_and_usage_exact
          source text sha256
          e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
          start
          32
          qualifier mentions
          1. context exact
            on of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis.
            kind
            age
            polarity
            not_inferred
            span
            end
            251
            end exclusive
            true
            exact text
            adult patients
            label id
            04bedd16-44e8-4761-bb65-d4678c4013af
            offset unit
            unicode_code_points
            source array index
            0
            source field
            indications_and_usage_exact
            source text sha256
            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
            start
            237
          regulatory links
            schema version
            0.1.0
            source batch sha256
            0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
            source defined aliases
              source span
              end
              308
              end exclusive
              true
              exact text
              • Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis.
              label id
              04bedd16-44e8-4761-bb65-d4678c4013af
              offset unit
              unicode_code_points
              source array index
              0
              source field
              indications_and_usage_exact
              source text sha256
              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
              start
              88
              source url
              https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
              spl effective date
              2025-10-17
              spl set id
              3e303a4a-980b-4f2a-9d03-786928758637
              spl version
              7
              structured fields status
              not_extracted_no_values_inferred_from_mentions
              structured indication
              age
              Source null
              approval pathway
              Source null
              biomarker and test
              Source null
              disease stage
              Source null
              limitations
              Source null
              line
              Source null
              prior therapy
              Source null
              regimen
              Source null
              tumor histology
              Source null
              use intent
              non_oncology_or_unclear_candidate
              Passage 3 · unclassified context
              application numbers
              1. BLA761071
              brand names
              1. HYRIMOZ
              classification reasons
              1. no_unambiguous_positive_indication_predicate
              clinical review status
              pending
              content role
              unclassified_context
              context span
              end
              514
              end exclusive
              true
              exact text
              symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. (1.1) • Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. (1.2) • Reducing signs and symptoms, inhibiting the pr
              label id
              04bedd16-44e8-4761-bb65-d4678c4013af
              offset unit
              unicode_code_points
              source array index
              0
              source field
              indications_and_usage_exact
              source text sha256
              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
              start
              109
              current approval status
              not_reconciled
              duplicate text group
              dup-311904a9b47931286a74
              extraction review status
              automated_candidate_pending_source_review
              generic names
              1. ADALIMUMAB-ADAZ
              id
              ind-span-1d9728f945d7d1e8634c
              label id
              04bedd16-44e8-4761-bb65-d4678c4013af
              positive predicate support span
              Source null
              qualifier mentions
                regulatory links
                  schema version
                  0.1.0
                  source batch sha256
                  0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                  source defined aliases
                    source span
                    end
                    314
                    end exclusive
                    true
                    exact text
                    (1.1)
                    label id
                    04bedd16-44e8-4761-bb65-d4678c4013af
                    offset unit
                    unicode_code_points
                    source array index
                    0
                    source field
                    indications_and_usage_exact
                    source text sha256
                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                    start
                    309
                    source url
                    https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                    spl effective date
                    2025-10-17
                    spl set id
                    3e303a4a-980b-4f2a-9d03-786928758637
                    spl version
                    7
                    structured fields status
                    not_extracted_no_values_inferred_from_mentions
                    structured indication
                    age
                    Source null
                    approval pathway
                    Source null
                    biomarker and test
                    Source null
                    disease stage
                    Source null
                    limitations
                    Source null
                    line
                    Source null
                    prior therapy
                    Source null
                    regimen
                    Source null
                    tumor histology
                    Source null
                    use intent
                    unclear
                    Passage 4 · unclassified context
                    application numbers
                    1. BLA761071
                    brand names
                    1. HYRIMOZ
                    classification reasons
                    1. no_unambiguous_positive_indication_predicate
                    clinical review status
                    pending
                    content role
                    unclassified_context
                    context span
                    end
                    659
                    end exclusive
                    true
                    exact text
                    ms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. (1.1) • Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. (1.2) • Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis. (1.3) • Reducing signs and sym
                    label id
                    04bedd16-44e8-4761-bb65-d4678c4013af
                    offset unit
                    unicode_code_points
                    source array index
                    0
                    source field
                    indications_and_usage_exact
                    source text sha256
                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                    start
                    115
                    current approval status
                    not_reconciled
                    duplicate text group
                    dup-36ca8988f7b97d34df59
                    extraction review status
                    automated_candidate_pending_source_review
                    generic names
                    1. ADALIMUMAB-ADAZ
                    id
                    ind-span-c8750a27c9e1a6d68a8c
                    label id
                    04bedd16-44e8-4761-bb65-d4678c4013af
                    positive predicate support span
                    Source null
                    qualifier mentions
                    1. context exact
                      ive polyarticular juvenile idiopathic arthritis in patients 2 years of age and older.
                      kind
                      age
                      polarity
                      not_inferred
                      span
                      end
                      448
                      end exclusive
                      true
                      exact text
                      2 years of age
                      label id
                      04bedd16-44e8-4761-bb65-d4678c4013af
                      offset unit
                      unicode_code_points
                      source array index
                      0
                      source field
                      indications_and_usage_exact
                      source text sha256
                      e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                      start
                      434
                    regulatory links
                      schema version
                      0.1.0
                      source batch sha256
                      0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                      source defined aliases
                        source span
                        end
                        459
                        end exclusive
                        true
                        exact text
                        • Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older.
                        label id
                        04bedd16-44e8-4761-bb65-d4678c4013af
                        offset unit
                        unicode_code_points
                        source array index
                        0
                        source field
                        indications_and_usage_exact
                        source text sha256
                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                        start
                        315
                        source url
                        https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                        spl effective date
                        2025-10-17
                        spl set id
                        3e303a4a-980b-4f2a-9d03-786928758637
                        spl version
                        7
                        structured fields status
                        not_extracted_no_values_inferred_from_mentions
                        structured indication
                        age
                        Source null
                        approval pathway
                        Source null
                        biomarker and test
                        Source null
                        disease stage
                        Source null
                        limitations
                        Source null
                        line
                        Source null
                        prior therapy
                        Source null
                        regimen
                        Source null
                        tumor histology
                        Source null
                        use intent
                        unclear
                        Passage 5 · unclassified context
                        application numbers
                        1. BLA761071
                        brand names
                        1. HYRIMOZ
                        classification reasons
                        1. no_unambiguous_positive_indication_predicate
                        clinical review status
                        pending
                        content role
                        unclassified_context
                        context span
                        end
                        665
                        end exclusive
                        true
                        exact text
                        erately to severely active rheumatoid arthritis. (1.1) • Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. (1.2) • Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis. (1.3) • Reducing signs and symptoms
                        label id
                        04bedd16-44e8-4761-bb65-d4678c4013af
                        offset unit
                        unicode_code_points
                        source array index
                        0
                        source field
                        indications_and_usage_exact
                        source text sha256
                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                        start
                        260
                        current approval status
                        not_reconciled
                        duplicate text group
                        dup-8f5d7b8505658be3ba20
                        extraction review status
                        automated_candidate_pending_source_review
                        generic names
                        1. ADALIMUMAB-ADAZ
                        id
                        ind-span-9eeb31c15caafbe45c48
                        label id
                        04bedd16-44e8-4761-bb65-d4678c4013af
                        positive predicate support span
                        Source null
                        qualifier mentions
                          regulatory links
                            schema version
                            0.1.0
                            source batch sha256
                            0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                            source defined aliases
                              source span
                              end
                              465
                              end exclusive
                              true
                              exact text
                              (1.2)
                              label id
                              04bedd16-44e8-4761-bb65-d4678c4013af
                              offset unit
                              unicode_code_points
                              source array index
                              0
                              source field
                              indications_and_usage_exact
                              source text sha256
                              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                              start
                              460
                              source url
                              https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                              spl effective date
                              2025-10-17
                              spl set id
                              3e303a4a-980b-4f2a-9d03-786928758637
                              spl version
                              7
                              structured fields status
                              not_extracted_no_values_inferred_from_mentions
                              structured indication
                              age
                              Source null
                              approval pathway
                              Source null
                              biomarker and test
                              Source null
                              disease stage
                              Source null
                              limitations
                              Source null
                              line
                              Source null
                              prior therapy
                              Source null
                              regimen
                              Source null
                              tumor histology
                              Source null
                              use intent
                              unclear
                              Passage 6 · positive indication candidate
                              application numbers
                              1. BLA761071
                              brand names
                              1. HYRIMOZ
                              classification reasons
                              1. inherited_predicate_from_same_label_section_requires_review
                              2. no_tumor_directed_keyword_in_positive_statement
                              clinical review status
                              pending
                              content role
                              positive_indication_candidate
                              context span
                              end
                              828
                              end exclusive
                              true
                              exact text
                              y to severely active rheumatoid arthritis. (1.1) • Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. (1.2) • Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis. (1.3) • Reducing signs and symptoms in adult patients with active ankylosing spondylitis. (1.4) • Treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years o
                              label id
                              04bedd16-44e8-4761-bb65-d4678c4013af
                              offset unit
                              unicode_code_points
                              source array index
                              0
                              source field
                              indications_and_usage_exact
                              source text sha256
                              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                              start
                              266
                              current approval status
                              not_reconciled
                              duplicate text group
                              dup-703a7d6e86af8b88102c
                              extraction review status
                              automated_candidate_pending_source_review
                              generic names
                              1. ADALIMUMAB-ADAZ
                              id
                              ind-span-bceebbb3156f8b840257
                              label id
                              04bedd16-44e8-4761-bb65-d4678c4013af
                              positive predicate support span
                              end
                              82
                              end exclusive
                              true
                              exact text
                              is a tumor necrosis factor (TNF)-blocker indicated
                              label id
                              04bedd16-44e8-4761-bb65-d4678c4013af
                              offset unit
                              unicode_code_points
                              source array index
                              0
                              source field
                              indications_and_usage_exact
                              source text sha256
                              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                              start
                              32
                              qualifier mentions
                              1. context exact
                                on of structural damage, and improving physical function in adult patients with active psoriatic arthritis.
                                kind
                                age
                                polarity
                                not_inferred
                                span
                                end
                                595
                                end exclusive
                                true
                                exact text
                                adult patients
                                label id
                                04bedd16-44e8-4761-bb65-d4678c4013af
                                offset unit
                                unicode_code_points
                                source array index
                                0
                                source field
                                indications_and_usage_exact
                                source text sha256
                                e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                start
                                581
                              regulatory links
                                schema version
                                0.1.0
                                source batch sha256
                                0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                source defined aliases
                                  source span
                                  end
                                  628
                                  end exclusive
                                  true
                                  exact text
                                  • Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis.
                                  label id
                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                  offset unit
                                  unicode_code_points
                                  source array index
                                  0
                                  source field
                                  indications_and_usage_exact
                                  source text sha256
                                  e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                  start
                                  466
                                  source url
                                  https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                  spl effective date
                                  2025-10-17
                                  spl set id
                                  3e303a4a-980b-4f2a-9d03-786928758637
                                  spl version
                                  7
                                  structured fields status
                                  not_extracted_no_values_inferred_from_mentions
                                  structured indication
                                  age
                                  Source null
                                  approval pathway
                                  Source null
                                  biomarker and test
                                  Source null
                                  disease stage
                                  Source null
                                  limitations
                                  Source null
                                  line
                                  Source null
                                  prior therapy
                                  Source null
                                  regimen
                                  Source null
                                  tumor histology
                                  Source null
                                  use intent
                                  non_oncology_or_unclear_candidate
                                  Passage 7 · unclassified context
                                  application numbers
                                  1. BLA761071
                                  brand names
                                  1. HYRIMOZ
                                  classification reasons
                                  1. no_unambiguous_positive_indication_predicate
                                  clinical review status
                                  pending
                                  content role
                                  unclassified_context
                                  context span
                                  end
                                  834
                                  end exclusive
                                  true
                                  exact text
                                  ents 2 years of age and older. (1.2) • Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis. (1.3) • Reducing signs and symptoms in adult patients with active ankylosing spondylitis. (1.4) • Treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age
                                  label id
                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                  offset unit
                                  unicode_code_points
                                  source array index
                                  0
                                  source field
                                  indications_and_usage_exact
                                  source text sha256
                                  e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                  start
                                  429
                                  current approval status
                                  not_reconciled
                                  duplicate text group
                                  dup-5e87d1295c8881af7106
                                  extraction review status
                                  automated_candidate_pending_source_review
                                  generic names
                                  1. ADALIMUMAB-ADAZ
                                  id
                                  ind-span-6d2251caf2c519dc27ae
                                  label id
                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                  positive predicate support span
                                  Source null
                                  qualifier mentions
                                    regulatory links
                                      schema version
                                      0.1.0
                                      source batch sha256
                                      0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                      source defined aliases
                                        source span
                                        end
                                        634
                                        end exclusive
                                        true
                                        exact text
                                        (1.3)
                                        label id
                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                        offset unit
                                        unicode_code_points
                                        source array index
                                        0
                                        source field
                                        indications_and_usage_exact
                                        source text sha256
                                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                        start
                                        629
                                        source url
                                        https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                        spl effective date
                                        2025-10-17
                                        spl set id
                                        3e303a4a-980b-4f2a-9d03-786928758637
                                        spl version
                                        7
                                        structured fields status
                                        not_extracted_no_values_inferred_from_mentions
                                        structured indication
                                        age
                                        Source null
                                        approval pathway
                                        Source null
                                        biomarker and test
                                        Source null
                                        disease stage
                                        Source null
                                        limitations
                                        Source null
                                        line
                                        Source null
                                        prior therapy
                                        Source null
                                        regimen
                                        Source null
                                        tumor histology
                                        Source null
                                        use intent
                                        unclear
                                        Passage 8 · positive indication candidate
                                        application numbers
                                        1. BLA761071
                                        brand names
                                        1. HYRIMOZ
                                        classification reasons
                                        1. inherited_predicate_from_same_label_section_requires_review
                                        2. no_tumor_directed_keyword_in_positive_statement
                                        clinical review status
                                        pending
                                        content role
                                        positive_indication_candidate
                                        context span
                                        end
                                        918
                                        end exclusive
                                        true
                                        exact text
                                        years of age and older. (1.2) • Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis. (1.3) • Reducing signs and symptoms in adult patients with active ankylosing spondylitis. (1.4) • Treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older. (1.5) • Treatment of moderately to severely active ulcerative colitis in
                                        label id
                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                        offset unit
                                        unicode_code_points
                                        source array index
                                        0
                                        source field
                                        indications_and_usage_exact
                                        source text sha256
                                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                        start
                                        435
                                        current approval status
                                        not_reconciled
                                        duplicate text group
                                        dup-d7af3954ae228a2ae950
                                        extraction review status
                                        automated_candidate_pending_source_review
                                        generic names
                                        1. ADALIMUMAB-ADAZ
                                        id
                                        ind-span-c6721830ce05f446bd2a
                                        label id
                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                        positive predicate support span
                                        end
                                        82
                                        end exclusive
                                        true
                                        exact text
                                        is a tumor necrosis factor (TNF)-blocker indicated
                                        label id
                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                        offset unit
                                        unicode_code_points
                                        source array index
                                        0
                                        source field
                                        indications_and_usage_exact
                                        source text sha256
                                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                        start
                                        32
                                        qualifier mentions
                                        1. context exact
                                          • Reducing signs and symptoms in adult patients with active ankylosing spondylitis.
                                          kind
                                          age
                                          polarity
                                          not_inferred
                                          span
                                          end
                                          682
                                          end exclusive
                                          true
                                          exact text
                                          adult patients
                                          label id
                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                          offset unit
                                          unicode_code_points
                                          source array index
                                          0
                                          source field
                                          indications_and_usage_exact
                                          source text sha256
                                          e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                          start
                                          668
                                        regulatory links
                                          schema version
                                          0.1.0
                                          source batch sha256
                                          0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                          source defined aliases
                                            source span
                                            end
                                            718
                                            end exclusive
                                            true
                                            exact text
                                            • Reducing signs and symptoms in adult patients with active ankylosing spondylitis.
                                            label id
                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                            offset unit
                                            unicode_code_points
                                            source array index
                                            0
                                            source field
                                            indications_and_usage_exact
                                            source text sha256
                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                            start
                                            635
                                            source url
                                            https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                            spl effective date
                                            2025-10-17
                                            spl set id
                                            3e303a4a-980b-4f2a-9d03-786928758637
                                            spl version
                                            7
                                            structured fields status
                                            not_extracted_no_values_inferred_from_mentions
                                            structured indication
                                            age
                                            Source null
                                            approval pathway
                                            Source null
                                            biomarker and test
                                            Source null
                                            disease stage
                                            Source null
                                            limitations
                                            Source null
                                            line
                                            Source null
                                            prior therapy
                                            Source null
                                            regimen
                                            Source null
                                            tumor histology
                                            Source null
                                            use intent
                                            non_oncology_or_unclear_candidate
                                            Passage 9 · unclassified context
                                            application numbers
                                            1. BLA761071
                                            brand names
                                            1. HYRIMOZ
                                            classification reasons
                                            1. no_unambiguous_positive_indication_predicate
                                            clinical review status
                                            pending
                                            content role
                                            unclassified_context
                                            context span
                                            end
                                            924
                                            end exclusive
                                            true
                                            exact text
                                            sion of structural damage, and improving physical function in adult patients with active psoriatic arthritis. (1.3) • Reducing signs and symptoms in adult patients with active ankylosing spondylitis. (1.4) • Treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older. (1.5) • Treatment of moderately to severely active ulcerative colitis in adult
                                            label id
                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                            offset unit
                                            unicode_code_points
                                            source array index
                                            0
                                            source field
                                            indications_and_usage_exact
                                            source text sha256
                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                            start
                                            519
                                            current approval status
                                            not_reconciled
                                            duplicate text group
                                            dup-73fa1659ce4b84f6ef3d
                                            extraction review status
                                            automated_candidate_pending_source_review
                                            generic names
                                            1. ADALIMUMAB-ADAZ
                                            id
                                            ind-span-fa4bd59c95aef7d67f07
                                            label id
                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                            positive predicate support span
                                            Source null
                                            qualifier mentions
                                              regulatory links
                                                schema version
                                                0.1.0
                                                source batch sha256
                                                0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                source defined aliases
                                                  source span
                                                  end
                                                  724
                                                  end exclusive
                                                  true
                                                  exact text
                                                  (1.4)
                                                  label id
                                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                                  offset unit
                                                  unicode_code_points
                                                  source array index
                                                  0
                                                  source field
                                                  indications_and_usage_exact
                                                  source text sha256
                                                  e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                  start
                                                  719
                                                  source url
                                                  https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                  spl effective date
                                                  2025-10-17
                                                  spl set id
                                                  3e303a4a-980b-4f2a-9d03-786928758637
                                                  spl version
                                                  7
                                                  structured fields status
                                                  not_extracted_no_values_inferred_from_mentions
                                                  structured indication
                                                  age
                                                  Source null
                                                  approval pathway
                                                  Source null
                                                  biomarker and test
                                                  Source null
                                                  disease stage
                                                  Source null
                                                  limitations
                                                  Source null
                                                  line
                                                  Source null
                                                  prior therapy
                                                  Source null
                                                  regimen
                                                  Source null
                                                  tumor histology
                                                  Source null
                                                  use intent
                                                  unclear
                                                  Passage 10 · positive indication candidate
                                                  application numbers
                                                  1. BLA761071
                                                  brand names
                                                  1. HYRIMOZ
                                                  classification reasons
                                                  1. inherited_predicate_from_same_label_section_requires_review
                                                  2. no_tumor_directed_keyword_in_positive_statement
                                                  clinical review status
                                                  pending
                                                  content role
                                                  positive_indication_candidate
                                                  context span
                                                  end
                                                  1044
                                                  end exclusive
                                                  true
                                                  exact text
                                                  f structural damage, and improving physical function in adult patients with active psoriatic arthritis. (1.3) • Reducing signs and symptoms in adult patients with active ankylosing spondylitis. (1.4) • Treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older. (1.5) • Treatment of moderately to severely active ulcerative colitis in adult patients. ( 1.6 ) Limitations of Use : Effectiveness has not been established in patients who have lost response to or w
                                                  label id
                                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                                  offset unit
                                                  unicode_code_points
                                                  source array index
                                                  0
                                                  source field
                                                  indications_and_usage_exact
                                                  source text sha256
                                                  e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                  start
                                                  525
                                                  current approval status
                                                  not_reconciled
                                                  duplicate text group
                                                  dup-6db638cd87a921b259bf
                                                  extraction review status
                                                  automated_candidate_pending_source_review
                                                  generic names
                                                  1. ADALIMUMAB-ADAZ
                                                  id
                                                  ind-span-a9122aefa64d57aa6b0f
                                                  label id
                                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                                  positive predicate support span
                                                  end
                                                  82
                                                  end exclusive
                                                  true
                                                  exact text
                                                  is a tumor necrosis factor (TNF)-blocker indicated
                                                  label id
                                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                                  offset unit
                                                  unicode_code_points
                                                  source array index
                                                  0
                                                  source field
                                                  indications_and_usage_exact
                                                  source text sha256
                                                  e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                  start
                                                  32
                                                  qualifier mentions
                                                  1. context exact
                                                    eatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older.
                                                    kind
                                                    age
                                                    polarity
                                                    not_inferred
                                                    span
                                                    end
                                                    795
                                                    end exclusive
                                                    true
                                                    exact text
                                                    adults
                                                    label id
                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                    offset unit
                                                    unicode_code_points
                                                    source array index
                                                    0
                                                    source field
                                                    indications_and_usage_exact
                                                    source text sha256
                                                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                    start
                                                    789
                                                  2. context exact
                                                    moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older.
                                                    kind
                                                    age
                                                    polarity
                                                    not_inferred
                                                    span
                                                    end
                                                    818
                                                    end exclusive
                                                    true
                                                    exact text
                                                    pediatric patients
                                                    label id
                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                    offset unit
                                                    unicode_code_points
                                                    source array index
                                                    0
                                                    source field
                                                    indications_and_usage_exact
                                                    source text sha256
                                                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                    start
                                                    800
                                                  3. context exact
                                                    ely active Crohn’s disease in adults and pediatric patients 6 years of age and older.
                                                    kind
                                                    age
                                                    polarity
                                                    not_inferred
                                                    span
                                                    end
                                                    833
                                                    end exclusive
                                                    true
                                                    exact text
                                                    6 years of age
                                                    label id
                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                    offset unit
                                                    unicode_code_points
                                                    source array index
                                                    0
                                                    source field
                                                    indications_and_usage_exact
                                                    source text sha256
                                                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                    start
                                                    819
                                                  regulatory links
                                                    schema version
                                                    0.1.0
                                                    source batch sha256
                                                    0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                    source defined aliases
                                                      source span
                                                      end
                                                      844
                                                      end exclusive
                                                      true
                                                      exact text
                                                      • Treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older.
                                                      label id
                                                      04bedd16-44e8-4761-bb65-d4678c4013af
                                                      offset unit
                                                      unicode_code_points
                                                      source array index
                                                      0
                                                      source field
                                                      indications_and_usage_exact
                                                      source text sha256
                                                      e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                      start
                                                      725
                                                      source url
                                                      https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                      spl effective date
                                                      2025-10-17
                                                      spl set id
                                                      3e303a4a-980b-4f2a-9d03-786928758637
                                                      spl version
                                                      7
                                                      structured fields status
                                                      not_extracted_no_values_inferred_from_mentions
                                                      structured indication
                                                      age
                                                      Source null
                                                      approval pathway
                                                      Source null
                                                      biomarker and test
                                                      Source null
                                                      disease stage
                                                      Source null
                                                      limitations
                                                      Source null
                                                      line
                                                      Source null
                                                      prior therapy
                                                      Source null
                                                      regimen
                                                      Source null
                                                      tumor histology
                                                      Source null
                                                      use intent
                                                      non_oncology_or_unclear_candidate
                                                      Passage 11 · unclassified context
                                                      application numbers
                                                      1. BLA761071
                                                      brand names
                                                      1. HYRIMOZ
                                                      classification reasons
                                                      1. no_unambiguous_positive_indication_predicate
                                                      clinical review status
                                                      pending
                                                      content role
                                                      unclassified_context
                                                      context span
                                                      end
                                                      1050
                                                      end exclusive
                                                      true
                                                      exact text
                                                      signs and symptoms in adult patients with active ankylosing spondylitis. (1.4) • Treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older. (1.5) • Treatment of moderately to severely active ulcerative colitis in adult patients. ( 1.6 ) Limitations of Use : Effectiveness has not been established in patients who have lost response to or were in
                                                      label id
                                                      04bedd16-44e8-4761-bb65-d4678c4013af
                                                      offset unit
                                                      unicode_code_points
                                                      source array index
                                                      0
                                                      source field
                                                      indications_and_usage_exact
                                                      source text sha256
                                                      e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                      start
                                                      645
                                                      current approval status
                                                      not_reconciled
                                                      duplicate text group
                                                      dup-00047432f00c88fe3767
                                                      extraction review status
                                                      automated_candidate_pending_source_review
                                                      generic names
                                                      1. ADALIMUMAB-ADAZ
                                                      id
                                                      ind-span-8446adf93b408fbf4fdd
                                                      label id
                                                      04bedd16-44e8-4761-bb65-d4678c4013af
                                                      positive predicate support span
                                                      Source null
                                                      qualifier mentions
                                                        regulatory links
                                                          schema version
                                                          0.1.0
                                                          source batch sha256
                                                          0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                          source defined aliases
                                                            source span
                                                            end
                                                            850
                                                            end exclusive
                                                            true
                                                            exact text
                                                            (1.5)
                                                            label id
                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                            offset unit
                                                            unicode_code_points
                                                            source array index
                                                            0
                                                            source field
                                                            indications_and_usage_exact
                                                            source text sha256
                                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                            start
                                                            845
                                                            source url
                                                            https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                            spl effective date
                                                            2025-10-17
                                                            spl set id
                                                            3e303a4a-980b-4f2a-9d03-786928758637
                                                            spl version
                                                            7
                                                            structured fields status
                                                            not_extracted_no_values_inferred_from_mentions
                                                            structured indication
                                                            age
                                                            Source null
                                                            approval pathway
                                                            Source null
                                                            biomarker and test
                                                            Source null
                                                            disease stage
                                                            Source null
                                                            limitations
                                                            Source null
                                                            line
                                                            Source null
                                                            prior therapy
                                                            Source null
                                                            regimen
                                                            Source null
                                                            tumor histology
                                                            Source null
                                                            use intent
                                                            unclear
                                                            Passage 12 · unclassified context
                                                            application numbers
                                                            1. BLA761071
                                                            brand names
                                                            1. HYRIMOZ
                                                            classification reasons
                                                            1. no_unambiguous_positive_indication_predicate
                                                            clinical review status
                                                            pending
                                                            content role
                                                            unclassified_context
                                                            context span
                                                            end
                                                            1133
                                                            end exclusive
                                                            true
                                                            exact text
                                                            and symptoms in adult patients with active ankylosing spondylitis. (1.4) • Treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older. (1.5) • Treatment of moderately to severely active ulcerative colitis in adult patients. ( 1.6 ) Limitations of Use : Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers. • Treatment of adult patients with moderate to severe chr
                                                            label id
                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                            offset unit
                                                            unicode_code_points
                                                            source array index
                                                            0
                                                            source field
                                                            indications_and_usage_exact
                                                            source text sha256
                                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                            start
                                                            651
                                                            current approval status
                                                            not_reconciled
                                                            duplicate text group
                                                            dup-53056e221ccb767022c5
                                                            extraction review status
                                                            automated_candidate_pending_source_review
                                                            generic names
                                                            1. ADALIMUMAB-ADAZ
                                                            id
                                                            ind-span-1b1063d065cad63e44be
                                                            label id
                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                            positive predicate support span
                                                            Source null
                                                            qualifier mentions
                                                            1. context exact
                                                              ment of moderately to severely active ulcerative colitis in adult patients.
                                                              kind
                                                              age
                                                              polarity
                                                              not_inferred
                                                              span
                                                              end
                                                              932
                                                              end exclusive
                                                              true
                                                              exact text
                                                              adult patients
                                                              label id
                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                              offset unit
                                                              unicode_code_points
                                                              source array index
                                                              0
                                                              source field
                                                              indications_and_usage_exact
                                                              source text sha256
                                                              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                              start
                                                              918
                                                            regulatory links
                                                              schema version
                                                              0.1.0
                                                              source batch sha256
                                                              0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                              source defined aliases
                                                                source span
                                                                end
                                                                933
                                                                end exclusive
                                                                true
                                                                exact text
                                                                • Treatment of moderately to severely active ulcerative colitis in adult patients.
                                                                label id
                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                offset unit
                                                                unicode_code_points
                                                                source array index
                                                                0
                                                                source field
                                                                indications_and_usage_exact
                                                                source text sha256
                                                                e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                start
                                                                851
                                                                source url
                                                                https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                spl effective date
                                                                2025-10-17
                                                                spl set id
                                                                3e303a4a-980b-4f2a-9d03-786928758637
                                                                spl version
                                                                7
                                                                structured fields status
                                                                not_extracted_no_values_inferred_from_mentions
                                                                structured indication
                                                                age
                                                                Source null
                                                                approval pathway
                                                                Source null
                                                                biomarker and test
                                                                Source null
                                                                disease stage
                                                                Source null
                                                                limitations
                                                                Source null
                                                                line
                                                                Source null
                                                                prior therapy
                                                                Source null
                                                                regimen
                                                                Source null
                                                                tumor histology
                                                                Source null
                                                                use intent
                                                                unclear
                                                                Passage 13 · limitation of use
                                                                application numbers
                                                                1. BLA761071
                                                                brand names
                                                                1. HYRIMOZ
                                                                classification reasons
                                                                1. negative_or_not_established_clause
                                                                clinical review status
                                                                pending
                                                                content role
                                                                limitation_of_use
                                                                context span
                                                                end
                                                                1275
                                                                end exclusive
                                                                true
                                                                exact text
                                                                nt of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older. (1.5) • Treatment of moderately to severely active ulcerative colitis in adult patients. ( 1.6 ) Limitations of Use : Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers. • Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriat
                                                                label id
                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                offset unit
                                                                unicode_code_points
                                                                source array index
                                                                0
                                                                source field
                                                                indications_and_usage_exact
                                                                source text sha256
                                                                e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                start
                                                                734
                                                                current approval status
                                                                not_reconciled
                                                                duplicate text group
                                                                dup-4487f9f66e62a4e27d18
                                                                extraction review status
                                                                automated_candidate_pending_source_review
                                                                generic names
                                                                1. ADALIMUMAB-ADAZ
                                                                id
                                                                ind-span-dff238aeeed785ac67d2
                                                                label id
                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                positive predicate support span
                                                                Source null
                                                                qualifier mentions
                                                                  regulatory links
                                                                    schema version
                                                                    0.1.0
                                                                    source batch sha256
                                                                    0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                    source defined aliases
                                                                      source span
                                                                      end
                                                                      1075
                                                                      end exclusive
                                                                      true
                                                                      exact text
                                                                      ( 1.6 ) Limitations of Use : Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers.
                                                                      label id
                                                                      04bedd16-44e8-4761-bb65-d4678c4013af
                                                                      offset unit
                                                                      unicode_code_points
                                                                      source array index
                                                                      0
                                                                      source field
                                                                      indications_and_usage_exact
                                                                      source text sha256
                                                                      e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                      start
                                                                      934
                                                                      source url
                                                                      https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                      spl effective date
                                                                      2025-10-17
                                                                      spl set id
                                                                      3e303a4a-980b-4f2a-9d03-786928758637
                                                                      spl version
                                                                      7
                                                                      structured fields status
                                                                      not_extracted_no_values_inferred_from_mentions
                                                                      structured indication
                                                                      age
                                                                      Source null
                                                                      approval pathway
                                                                      Source null
                                                                      biomarker and test
                                                                      Source null
                                                                      disease stage
                                                                      Source null
                                                                      limitations
                                                                      Source null
                                                                      line
                                                                      Source null
                                                                      prior therapy
                                                                      Source null
                                                                      regimen
                                                                      Source null
                                                                      tumor histology
                                                                      Source null
                                                                      use intent
                                                                      not_applicable
                                                                      Passage 14 · unclassified context
                                                                      application numbers
                                                                      1. BLA761071
                                                                      brand names
                                                                      1. HYRIMOZ
                                                                      classification reasons
                                                                      1. no_unambiguous_positive_indication_predicate
                                                                      clinical review status
                                                                      pending
                                                                      content role
                                                                      unclassified_context
                                                                      context span
                                                                      end
                                                                      1477
                                                                      end exclusive
                                                                      true
                                                                      exact text
                                                                      to severely active ulcerative colitis in adult patients. ( 1.6 ) Limitations of Use : Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers. • Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. ( 1.7 ) • Treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older. ( 1.8 ) • Treatment of non-infectious intermediate, posterior, and panuveitis in adults and p
                                                                      label id
                                                                      04bedd16-44e8-4761-bb65-d4678c4013af
                                                                      offset unit
                                                                      unicode_code_points
                                                                      source array index
                                                                      0
                                                                      source field
                                                                      indications_and_usage_exact
                                                                      source text sha256
                                                                      e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                      start
                                                                      876
                                                                      current approval status
                                                                      not_reconciled
                                                                      duplicate text group
                                                                      dup-1eb8cfc3083c96faff27
                                                                      extraction review status
                                                                      automated_candidate_pending_source_review
                                                                      generic names
                                                                      1. ADALIMUMAB-ADAZ
                                                                      id
                                                                      ind-span-d38aff07074e079b9529
                                                                      label id
                                                                      04bedd16-44e8-4761-bb65-d4678c4013af
                                                                      positive predicate support span
                                                                      Source null
                                                                      qualifier mentions
                                                                      1. context exact
                                                                        • Treatment of adult patients with moderate to severe chronic plaque psoriasis who are ca
                                                                        kind
                                                                        age
                                                                        polarity
                                                                        not_inferred
                                                                        span
                                                                        end
                                                                        1105
                                                                        end exclusive
                                                                        true
                                                                        exact text
                                                                        adult patients
                                                                        label id
                                                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                                                        offset unit
                                                                        unicode_code_points
                                                                        source array index
                                                                        0
                                                                        source field
                                                                        indications_and_usage_exact
                                                                        source text sha256
                                                                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                        start
                                                                        1091
                                                                      regulatory links
                                                                        schema version
                                                                        0.1.0
                                                                        source batch sha256
                                                                        0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                        source defined aliases
                                                                          source span
                                                                          end
                                                                          1277
                                                                          end exclusive
                                                                          true
                                                                          exact text
                                                                          • Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
                                                                          label id
                                                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                                                          offset unit
                                                                          unicode_code_points
                                                                          source array index
                                                                          0
                                                                          source field
                                                                          indications_and_usage_exact
                                                                          source text sha256
                                                                          e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                          start
                                                                          1076
                                                                          source url
                                                                          https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                          spl effective date
                                                                          2025-10-17
                                                                          spl set id
                                                                          3e303a4a-980b-4f2a-9d03-786928758637
                                                                          spl version
                                                                          7
                                                                          structured fields status
                                                                          not_extracted_no_values_inferred_from_mentions
                                                                          structured indication
                                                                          age
                                                                          Source null
                                                                          approval pathway
                                                                          Source null
                                                                          biomarker and test
                                                                          Source null
                                                                          disease stage
                                                                          Source null
                                                                          limitations
                                                                          Source null
                                                                          line
                                                                          Source null
                                                                          prior therapy
                                                                          Source null
                                                                          regimen
                                                                          Source null
                                                                          tumor histology
                                                                          Source null
                                                                          use intent
                                                                          unclear
                                                                          Passage 15 · unclassified context
                                                                          application numbers
                                                                          1. BLA761071
                                                                          brand names
                                                                          1. HYRIMOZ
                                                                          classification reasons
                                                                          1. no_unambiguous_positive_indication_predicate
                                                                          clinical review status
                                                                          pending
                                                                          content role
                                                                          unclassified_context
                                                                          context span
                                                                          end
                                                                          1485
                                                                          end exclusive
                                                                          true
                                                                          exact text
                                                                          Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. ( 1.7 ) • Treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older. ( 1.8 ) • Treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric
                                                                          label id
                                                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                                                          offset unit
                                                                          unicode_code_points
                                                                          source array index
                                                                          0
                                                                          source field
                                                                          indications_and_usage_exact
                                                                          source text sha256
                                                                          e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                          start
                                                                          1078
                                                                          current approval status
                                                                          not_reconciled
                                                                          duplicate text group
                                                                          dup-a1d0c0970a5548c8d604
                                                                          extraction review status
                                                                          automated_candidate_pending_source_review
                                                                          generic names
                                                                          1. ADALIMUMAB-ADAZ
                                                                          id
                                                                          ind-span-f251d7f25738f710fc6c
                                                                          label id
                                                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                                                          positive predicate support span
                                                                          Source null
                                                                          qualifier mentions
                                                                            regulatory links
                                                                              schema version
                                                                              0.1.0
                                                                              source batch sha256
                                                                              0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                              source defined aliases
                                                                                source span
                                                                                end
                                                                                1285
                                                                                end exclusive
                                                                                true
                                                                                exact text
                                                                                ( 1.7 )
                                                                                label id
                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                offset unit
                                                                                unicode_code_points
                                                                                source array index
                                                                                0
                                                                                source field
                                                                                indications_and_usage_exact
                                                                                source text sha256
                                                                                e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                start
                                                                                1278
                                                                                source url
                                                                                https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                spl effective date
                                                                                2025-10-17
                                                                                spl set id
                                                                                3e303a4a-980b-4f2a-9d03-786928758637
                                                                                spl version
                                                                                7
                                                                                structured fields status
                                                                                not_extracted_no_values_inferred_from_mentions
                                                                                structured indication
                                                                                age
                                                                                Source null
                                                                                approval pathway
                                                                                Source null
                                                                                biomarker and test
                                                                                Source null
                                                                                disease stage
                                                                                Source null
                                                                                limitations
                                                                                Source null
                                                                                line
                                                                                Source null
                                                                                prior therapy
                                                                                Source null
                                                                                regimen
                                                                                Source null
                                                                                tumor histology
                                                                                Source null
                                                                                use intent
                                                                                unclear
                                                                                Passage 16 · unclassified context
                                                                                application numbers
                                                                                1. BLA761071
                                                                                brand names
                                                                                1. HYRIMOZ
                                                                                classification reasons
                                                                                1. no_unambiguous_positive_indication_predicate
                                                                                clinical review status
                                                                                pending
                                                                                content role
                                                                                unclassified_context
                                                                                context span
                                                                                end
                                                                                1583
                                                                                end exclusive
                                                                                true
                                                                                exact text
                                                                                t of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. ( 1.7 ) • Treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older. ( 1.8 ) • Treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older. ( 1.9 ) 1.1 Rheumatoid Arthritis HYRIMOZ is indicated for redu
                                                                                label id
                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                offset unit
                                                                                unicode_code_points
                                                                                source array index
                                                                                0
                                                                                source field
                                                                                indications_and_usage_exact
                                                                                source text sha256
                                                                                e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                start
                                                                                1086
                                                                                current approval status
                                                                                not_reconciled
                                                                                duplicate text group
                                                                                dup-1e467726f81ce54c9955
                                                                                extraction review status
                                                                                automated_candidate_pending_source_review
                                                                                generic names
                                                                                1. ADALIMUMAB-ADAZ
                                                                                id
                                                                                ind-span-f0ba533e1e1202214a4e
                                                                                label id
                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                positive predicate support span
                                                                                Source null
                                                                                qualifier mentions
                                                                                1. context exact
                                                                                  of moderate to severe hidradenitis suppurativa in patients 12 years of age and older.
                                                                                  kind
                                                                                  age
                                                                                  polarity
                                                                                  not_inferred
                                                                                  span
                                                                                  end
                                                                                  1372
                                                                                  end exclusive
                                                                                  true
                                                                                  exact text
                                                                                  12 years of age
                                                                                  label id
                                                                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                  offset unit
                                                                                  unicode_code_points
                                                                                  source array index
                                                                                  0
                                                                                  source field
                                                                                  indications_and_usage_exact
                                                                                  source text sha256
                                                                                  e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                  start
                                                                                  1357
                                                                                regulatory links
                                                                                  schema version
                                                                                  0.1.0
                                                                                  source batch sha256
                                                                                  0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                  source defined aliases
                                                                                    source span
                                                                                    end
                                                                                    1383
                                                                                    end exclusive
                                                                                    true
                                                                                    exact text
                                                                                    • Treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older.
                                                                                    label id
                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                    offset unit
                                                                                    unicode_code_points
                                                                                    source array index
                                                                                    0
                                                                                    source field
                                                                                    indications_and_usage_exact
                                                                                    source text sha256
                                                                                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                    start
                                                                                    1286
                                                                                    source url
                                                                                    https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                    spl effective date
                                                                                    2025-10-17
                                                                                    spl set id
                                                                                    3e303a4a-980b-4f2a-9d03-786928758637
                                                                                    spl version
                                                                                    7
                                                                                    structured fields status
                                                                                    not_extracted_no_values_inferred_from_mentions
                                                                                    structured indication
                                                                                    age
                                                                                    Source null
                                                                                    approval pathway
                                                                                    Source null
                                                                                    biomarker and test
                                                                                    Source null
                                                                                    disease stage
                                                                                    Source null
                                                                                    limitations
                                                                                    Source null
                                                                                    line
                                                                                    Source null
                                                                                    prior therapy
                                                                                    Source null
                                                                                    regimen
                                                                                    Source null
                                                                                    tumor histology
                                                                                    Source null
                                                                                    use intent
                                                                                    unclear
                                                                                    Passage 17 · unclassified context
                                                                                    application numbers
                                                                                    1. BLA761071
                                                                                    brand names
                                                                                    1. HYRIMOZ
                                                                                    classification reasons
                                                                                    1. no_unambiguous_positive_indication_predicate
                                                                                    clinical review status
                                                                                    pending
                                                                                    content role
                                                                                    unclassified_context
                                                                                    context span
                                                                                    end
                                                                                    1591
                                                                                    end exclusive
                                                                                    true
                                                                                    exact text
                                                                                    ic therapy or phototherapy, and when other systemic therapies are medically less appropriate. ( 1.7 ) • Treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older. ( 1.8 ) • Treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older. ( 1.9 ) 1.1 Rheumatoid Arthritis HYRIMOZ is indicated for reducing sig
                                                                                    label id
                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                    offset unit
                                                                                    unicode_code_points
                                                                                    source array index
                                                                                    0
                                                                                    source field
                                                                                    indications_and_usage_exact
                                                                                    source text sha256
                                                                                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                    start
                                                                                    1184
                                                                                    current approval status
                                                                                    not_reconciled
                                                                                    duplicate text group
                                                                                    dup-81ca2af54fff49d5c8bf
                                                                                    extraction review status
                                                                                    automated_candidate_pending_source_review
                                                                                    generic names
                                                                                    1. ADALIMUMAB-ADAZ
                                                                                    id
                                                                                    ind-span-ba72f030a624cf0b7935
                                                                                    label id
                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                    positive predicate support span
                                                                                    Source null
                                                                                    qualifier mentions
                                                                                      regulatory links
                                                                                        schema version
                                                                                        0.1.0
                                                                                        source batch sha256
                                                                                        0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                        source defined aliases
                                                                                          source span
                                                                                          end
                                                                                          1391
                                                                                          end exclusive
                                                                                          true
                                                                                          exact text
                                                                                          ( 1.8 )
                                                                                          label id
                                                                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                          offset unit
                                                                                          unicode_code_points
                                                                                          source array index
                                                                                          0
                                                                                          source field
                                                                                          indications_and_usage_exact
                                                                                          source text sha256
                                                                                          e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                          start
                                                                                          1384
                                                                                          source url
                                                                                          https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                          spl effective date
                                                                                          2025-10-17
                                                                                          spl set id
                                                                                          3e303a4a-980b-4f2a-9d03-786928758637
                                                                                          spl version
                                                                                          7
                                                                                          structured fields status
                                                                                          not_extracted_no_values_inferred_from_mentions
                                                                                          structured indication
                                                                                          age
                                                                                          Source null
                                                                                          approval pathway
                                                                                          Source null
                                                                                          biomarker and test
                                                                                          Source null
                                                                                          disease stage
                                                                                          Source null
                                                                                          limitations
                                                                                          Source null
                                                                                          line
                                                                                          Source null
                                                                                          prior therapy
                                                                                          Source null
                                                                                          regimen
                                                                                          Source null
                                                                                          tumor histology
                                                                                          Source null
                                                                                          use intent
                                                                                          unclear
                                                                                          Passage 18 · unclassified context
                                                                                          application numbers
                                                                                          1. BLA761071
                                                                                          brand names
                                                                                          1. HYRIMOZ
                                                                                          classification reasons
                                                                                          1. no_unambiguous_positive_indication_predicate
                                                                                          clinical review status
                                                                                          pending
                                                                                          content role
                                                                                          unclassified_context
                                                                                          context span
                                                                                          end
                                                                                          1720
                                                                                          end exclusive
                                                                                          true
                                                                                          exact text
                                                                                          py or phototherapy, and when other systemic therapies are medically less appropriate. ( 1.7 ) • Treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older. ( 1.8 ) • Treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older. ( 1.9 ) 1.1 Rheumatoid Arthritis HYRIMOZ is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical functi
                                                                                          label id
                                                                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                          offset unit
                                                                                          unicode_code_points
                                                                                          source array index
                                                                                          0
                                                                                          source field
                                                                                          indications_and_usage_exact
                                                                                          source text sha256
                                                                                          e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                          start
                                                                                          1192
                                                                                          current approval status
                                                                                          not_reconciled
                                                                                          duplicate text group
                                                                                          dup-bdede893720d5859308e
                                                                                          extraction review status
                                                                                          automated_candidate_pending_source_review
                                                                                          generic names
                                                                                          1. ADALIMUMAB-ADAZ
                                                                                          id
                                                                                          ind-span-9520762016fbb64563d5
                                                                                          label id
                                                                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                          positive predicate support span
                                                                                          Source null
                                                                                          qualifier mentions
                                                                                          1. context exact
                                                                                            f non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.
                                                                                            kind
                                                                                            age
                                                                                            polarity
                                                                                            not_inferred
                                                                                            span
                                                                                            end
                                                                                            1471
                                                                                            end exclusive
                                                                                            true
                                                                                            exact text
                                                                                            adults
                                                                                            label id
                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                            offset unit
                                                                                            unicode_code_points
                                                                                            source array index
                                                                                            0
                                                                                            source field
                                                                                            indications_and_usage_exact
                                                                                            source text sha256
                                                                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                            start
                                                                                            1465
                                                                                          2. context exact
                                                                                            tious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.
                                                                                            kind
                                                                                            age
                                                                                            polarity
                                                                                            not_inferred
                                                                                            span
                                                                                            end
                                                                                            1494
                                                                                            end exclusive
                                                                                            true
                                                                                            exact text
                                                                                            pediatric patients
                                                                                            label id
                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                            offset unit
                                                                                            unicode_code_points
                                                                                            source array index
                                                                                            0
                                                                                            source field
                                                                                            indications_and_usage_exact
                                                                                            source text sha256
                                                                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                            start
                                                                                            1476
                                                                                          3. context exact
                                                                                            posterior, and panuveitis in adults and pediatric patients 2 years of age and older.
                                                                                            kind
                                                                                            age
                                                                                            polarity
                                                                                            not_inferred
                                                                                            span
                                                                                            end
                                                                                            1509
                                                                                            end exclusive
                                                                                            true
                                                                                            exact text
                                                                                            2 years of age
                                                                                            label id
                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                            offset unit
                                                                                            unicode_code_points
                                                                                            source array index
                                                                                            0
                                                                                            source field
                                                                                            indications_and_usage_exact
                                                                                            source text sha256
                                                                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                            start
                                                                                            1495
                                                                                          regulatory links
                                                                                            schema version
                                                                                            0.1.0
                                                                                            source batch sha256
                                                                                            0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                            source defined aliases
                                                                                              source span
                                                                                              end
                                                                                              1520
                                                                                              end exclusive
                                                                                              true
                                                                                              exact text
                                                                                              • Treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.
                                                                                              label id
                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                              offset unit
                                                                                              unicode_code_points
                                                                                              source array index
                                                                                              0
                                                                                              source field
                                                                                              indications_and_usage_exact
                                                                                              source text sha256
                                                                                              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                              start
                                                                                              1392
                                                                                              source url
                                                                                              https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                              spl effective date
                                                                                              2025-10-17
                                                                                              spl set id
                                                                                              3e303a4a-980b-4f2a-9d03-786928758637
                                                                                              spl version
                                                                                              7
                                                                                              structured fields status
                                                                                              not_extracted_no_values_inferred_from_mentions
                                                                                              structured indication
                                                                                              age
                                                                                              Source null
                                                                                              approval pathway
                                                                                              Source null
                                                                                              biomarker and test
                                                                                              Source null
                                                                                              disease stage
                                                                                              Source null
                                                                                              limitations
                                                                                              Source null
                                                                                              line
                                                                                              Source null
                                                                                              prior therapy
                                                                                              Source null
                                                                                              regimen
                                                                                              Source null
                                                                                              tumor histology
                                                                                              Source null
                                                                                              use intent
                                                                                              unclear
                                                                                              Passage 19 · unclassified context
                                                                                              application numbers
                                                                                              1. BLA761071
                                                                                              brand names
                                                                                              1. HYRIMOZ
                                                                                              classification reasons
                                                                                              1. no_unambiguous_positive_indication_predicate
                                                                                              clinical review status
                                                                                              pending
                                                                                              content role
                                                                                              unclassified_context
                                                                                              context span
                                                                                              end
                                                                                              1728
                                                                                              end exclusive
                                                                                              true
                                                                                              exact text
                                                                                              idradenitis suppurativa in patients 12 years of age and older. ( 1.8 ) • Treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older. ( 1.9 ) 1.1 Rheumatoid Arthritis HYRIMOZ is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in ad
                                                                                              label id
                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                              offset unit
                                                                                              unicode_code_points
                                                                                              source array index
                                                                                              0
                                                                                              source field
                                                                                              indications_and_usage_exact
                                                                                              source text sha256
                                                                                              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                              start
                                                                                              1321
                                                                                              current approval status
                                                                                              not_reconciled
                                                                                              duplicate text group
                                                                                              dup-d028686848c6036db0bc
                                                                                              extraction review status
                                                                                              automated_candidate_pending_source_review
                                                                                              generic names
                                                                                              1. ADALIMUMAB-ADAZ
                                                                                              id
                                                                                              ind-span-fb815447f134634364b3
                                                                                              label id
                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                              positive predicate support span
                                                                                              Source null
                                                                                              qualifier mentions
                                                                                                regulatory links
                                                                                                  schema version
                                                                                                  0.1.0
                                                                                                  source batch sha256
                                                                                                  0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                  source defined aliases
                                                                                                    source span
                                                                                                    end
                                                                                                    1528
                                                                                                    end exclusive
                                                                                                    true
                                                                                                    exact text
                                                                                                    ( 1.9 )
                                                                                                    label id
                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                    offset unit
                                                                                                    unicode_code_points
                                                                                                    source array index
                                                                                                    0
                                                                                                    source field
                                                                                                    indications_and_usage_exact
                                                                                                    source text sha256
                                                                                                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                    start
                                                                                                    1521
                                                                                                    source url
                                                                                                    https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                    spl effective date
                                                                                                    2025-10-17
                                                                                                    spl set id
                                                                                                    3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                    spl version
                                                                                                    7
                                                                                                    structured fields status
                                                                                                    not_extracted_no_values_inferred_from_mentions
                                                                                                    structured indication
                                                                                                    age
                                                                                                    Source null
                                                                                                    approval pathway
                                                                                                    Source null
                                                                                                    biomarker and test
                                                                                                    Source null
                                                                                                    disease stage
                                                                                                    Source null
                                                                                                    limitations
                                                                                                    Source null
                                                                                                    line
                                                                                                    Source null
                                                                                                    prior therapy
                                                                                                    Source null
                                                                                                    regimen
                                                                                                    Source null
                                                                                                    tumor histology
                                                                                                    Source null
                                                                                                    use intent
                                                                                                    unclear
                                                                                                    Passage 20 · positive indication candidate
                                                                                                    application numbers
                                                                                                    1. BLA761071
                                                                                                    brand names
                                                                                                    1. HYRIMOZ
                                                                                                    classification reasons
                                                                                                    1. explicit_positive_indication_predicate
                                                                                                    2. no_tumor_directed_keyword_in_positive_statement
                                                                                                    clinical review status
                                                                                                    pending
                                                                                                    content role
                                                                                                    positive_indication_candidate
                                                                                                    context span
                                                                                                    end
                                                                                                    1997
                                                                                                    end exclusive
                                                                                                    true
                                                                                                    exact text
                                                                                                    tis suppurativa in patients 12 years of age and older. ( 1.8 ) • Treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older. ( 1.9 ) 1.1 Rheumatoid Arthritis HYRIMOZ is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. HYRIMOZ can be used alone or in combination with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs). 1.2 Juvenile Idiopathic Arthritis HYRIMOZ is indicated for reducin
                                                                                                    label id
                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                    offset unit
                                                                                                    unicode_code_points
                                                                                                    source array index
                                                                                                    0
                                                                                                    source field
                                                                                                    indications_and_usage_exact
                                                                                                    source text sha256
                                                                                                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                    start
                                                                                                    1329
                                                                                                    current approval status
                                                                                                    not_reconciled
                                                                                                    duplicate text group
                                                                                                    dup-78c5538ab02b617a4b66
                                                                                                    extraction review status
                                                                                                    automated_candidate_pending_source_review
                                                                                                    generic names
                                                                                                    1. ADALIMUMAB-ADAZ
                                                                                                    id
                                                                                                    ind-span-2e322bfaba4645a362fb
                                                                                                    label id
                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                    positive predicate support span
                                                                                                    end
                                                                                                    1574
                                                                                                    end exclusive
                                                                                                    true
                                                                                                    exact text
                                                                                                    is indicated
                                                                                                    label id
                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                    offset unit
                                                                                                    unicode_code_points
                                                                                                    source array index
                                                                                                    0
                                                                                                    source field
                                                                                                    indications_and_usage_exact
                                                                                                    source text sha256
                                                                                                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                    start
                                                                                                    1562
                                                                                                    qualifier mentions
                                                                                                    1. context exact
                                                                                                      on of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis.
                                                                                                      kind
                                                                                                      age
                                                                                                      polarity
                                                                                                      not_inferred
                                                                                                      span
                                                                                                      end
                                                                                                      1740
                                                                                                      end exclusive
                                                                                                      true
                                                                                                      exact text
                                                                                                      adult patients
                                                                                                      label id
                                                                                                      04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                      offset unit
                                                                                                      unicode_code_points
                                                                                                      source array index
                                                                                                      0
                                                                                                      source field
                                                                                                      indications_and_usage_exact
                                                                                                      source text sha256
                                                                                                      e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                      start
                                                                                                      1726
                                                                                                    regulatory links
                                                                                                      schema version
                                                                                                      0.1.0
                                                                                                      source batch sha256
                                                                                                      0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                      source defined aliases
                                                                                                        source span
                                                                                                        end
                                                                                                        1797
                                                                                                        end exclusive
                                                                                                        true
                                                                                                        exact text
                                                                                                        1.1 Rheumatoid Arthritis HYRIMOZ is indicated for reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis.
                                                                                                        label id
                                                                                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                        offset unit
                                                                                                        unicode_code_points
                                                                                                        source array index
                                                                                                        0
                                                                                                        source field
                                                                                                        indications_and_usage_exact
                                                                                                        source text sha256
                                                                                                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                        start
                                                                                                        1529
                                                                                                        source url
                                                                                                        https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                        spl effective date
                                                                                                        2025-10-17
                                                                                                        spl set id
                                                                                                        3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                        spl version
                                                                                                        7
                                                                                                        structured fields status
                                                                                                        not_extracted_no_values_inferred_from_mentions
                                                                                                        structured indication
                                                                                                        age
                                                                                                        Source null
                                                                                                        approval pathway
                                                                                                        Source null
                                                                                                        biomarker and test
                                                                                                        Source null
                                                                                                        disease stage
                                                                                                        Source null
                                                                                                        limitations
                                                                                                        Source null
                                                                                                        line
                                                                                                        Source null
                                                                                                        prior therapy
                                                                                                        Source null
                                                                                                        regimen
                                                                                                        Source null
                                                                                                        tumor histology
                                                                                                        Source null
                                                                                                        use intent
                                                                                                        non_oncology_or_unclear_candidate
                                                                                                        Passage 21 · unclassified context
                                                                                                        application numbers
                                                                                                        1. BLA761071
                                                                                                        brand names
                                                                                                        1. HYRIMOZ
                                                                                                        classification reasons
                                                                                                        1. no_unambiguous_positive_indication_predicate
                                                                                                        clinical review status
                                                                                                        pending
                                                                                                        content role
                                                                                                        unclassified_context
                                                                                                        context span
                                                                                                        end
                                                                                                        2130
                                                                                                        end exclusive
                                                                                                        true
                                                                                                        exact text
                                                                                                        symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis. HYRIMOZ can be used alone or in combination with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs). 1.2 Juvenile Idiopathic Arthritis HYRIMOZ is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and olde
                                                                                                        label id
                                                                                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                        offset unit
                                                                                                        unicode_code_points
                                                                                                        source array index
                                                                                                        0
                                                                                                        source field
                                                                                                        indications_and_usage_exact
                                                                                                        source text sha256
                                                                                                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                        start
                                                                                                        1598
                                                                                                        current approval status
                                                                                                        not_reconciled
                                                                                                        duplicate text group
                                                                                                        dup-342efd93e7f84a5df47c
                                                                                                        extraction review status
                                                                                                        automated_candidate_pending_source_review
                                                                                                        generic names
                                                                                                        1. ADALIMUMAB-ADAZ
                                                                                                        id
                                                                                                        ind-span-0bbbd74a4a3fd31245ab
                                                                                                        label id
                                                                                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                        positive predicate support span
                                                                                                        Source null
                                                                                                        qualifier mentions
                                                                                                        1. context exact
                                                                                                          HYRIMOZ can be used alone or in combination with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs).
                                                                                                          kind
                                                                                                          biomarker
                                                                                                          polarity
                                                                                                          not_inferred
                                                                                                          span
                                                                                                          end
                                                                                                          1890
                                                                                                          end exclusive
                                                                                                          true
                                                                                                          exact text
                                                                                                          methotrexate or other non-biologic disease-
                                                                                                          label id
                                                                                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                          offset unit
                                                                                                          unicode_code_points
                                                                                                          source array index
                                                                                                          0
                                                                                                          source field
                                                                                                          indications_and_usage_exact
                                                                                                          source text sha256
                                                                                                          e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                          start
                                                                                                          1847
                                                                                                        2. context exact
                                                                                                          HYRIMOZ can be used alone or in combination with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs).
                                                                                                          kind
                                                                                                          regimen
                                                                                                          polarity
                                                                                                          not_inferred
                                                                                                          span
                                                                                                          end
                                                                                                          1929
                                                                                                          end exclusive
                                                                                                          true
                                                                                                          exact text
                                                                                                          in combination with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs)
                                                                                                          label id
                                                                                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                          offset unit
                                                                                                          unicode_code_points
                                                                                                          source array index
                                                                                                          0
                                                                                                          source field
                                                                                                          indications_and_usage_exact
                                                                                                          source text sha256
                                                                                                          e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                          start
                                                                                                          1827
                                                                                                        regulatory links
                                                                                                          schema version
                                                                                                          0.1.0
                                                                                                          source batch sha256
                                                                                                          0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                          source defined aliases
                                                                                                            source span
                                                                                                            end
                                                                                                            1930
                                                                                                            end exclusive
                                                                                                            true
                                                                                                            exact text
                                                                                                            HYRIMOZ can be used alone or in combination with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs).
                                                                                                            label id
                                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                            offset unit
                                                                                                            unicode_code_points
                                                                                                            source array index
                                                                                                            0
                                                                                                            source field
                                                                                                            indications_and_usage_exact
                                                                                                            source text sha256
                                                                                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                            start
                                                                                                            1798
                                                                                                            source url
                                                                                                            https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                            spl effective date
                                                                                                            2025-10-17
                                                                                                            spl set id
                                                                                                            3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                            spl version
                                                                                                            7
                                                                                                            structured fields status
                                                                                                            not_extracted_no_values_inferred_from_mentions
                                                                                                            structured indication
                                                                                                            age
                                                                                                            Source null
                                                                                                            approval pathway
                                                                                                            Source null
                                                                                                            biomarker and test
                                                                                                            Source null
                                                                                                            disease stage
                                                                                                            Source null
                                                                                                            limitations
                                                                                                            Source null
                                                                                                            line
                                                                                                            Source null
                                                                                                            prior therapy
                                                                                                            Source null
                                                                                                            regimen
                                                                                                            Source null
                                                                                                            tumor histology
                                                                                                            Source null
                                                                                                            use intent
                                                                                                            unclear
                                                                                                            Passage 22 · positive indication candidate
                                                                                                            application numbers
                                                                                                            1. BLA761071
                                                                                                            brand names
                                                                                                            1. HYRIMOZ
                                                                                                            classification reasons
                                                                                                            1. explicit_positive_indication_predicate
                                                                                                            2. no_tumor_directed_keyword_in_positive_statement
                                                                                                            clinical review status
                                                                                                            pending
                                                                                                            content role
                                                                                                            positive_indication_candidate
                                                                                                            context span
                                                                                                            end
                                                                                                            2332
                                                                                                            end exclusive
                                                                                                            true
                                                                                                            exact text
                                                                                                            patients with moderately to severely active rheumatoid arthritis. HYRIMOZ can be used alone or in combination with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs). 1.2 Juvenile Idiopathic Arthritis HYRIMOZ is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. HYRIMOZ can be used alone or in combination with methotrexate. 1.3 Psoriatic Arthritis HYRIMOZ is indicated for reducing signs and symptoms, inhibiting the progression of structural damage, and impro
                                                                                                            label id
                                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                            offset unit
                                                                                                            unicode_code_points
                                                                                                            source array index
                                                                                                            0
                                                                                                            source field
                                                                                                            indications_and_usage_exact
                                                                                                            source text sha256
                                                                                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                            start
                                                                                                            1731
                                                                                                            current approval status
                                                                                                            not_reconciled
                                                                                                            duplicate text group
                                                                                                            dup-d2e3210a7173ac48a5f3
                                                                                                            extraction review status
                                                                                                            automated_candidate_pending_source_review
                                                                                                            generic names
                                                                                                            1. ADALIMUMAB-ADAZ
                                                                                                            id
                                                                                                            ind-span-6cc485f1e489b8561b97
                                                                                                            label id
                                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                            positive predicate support span
                                                                                                            end
                                                                                                            1985
                                                                                                            end exclusive
                                                                                                            true
                                                                                                            exact text
                                                                                                            is indicated
                                                                                                            label id
                                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                            offset unit
                                                                                                            unicode_code_points
                                                                                                            source array index
                                                                                                            0
                                                                                                            source field
                                                                                                            indications_and_usage_exact
                                                                                                            source text sha256
                                                                                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                            start
                                                                                                            1973
                                                                                                            qualifier mentions
                                                                                                            1. context exact
                                                                                                              ive polyarticular juvenile idiopathic arthritis in patients 2 years of age and older.
                                                                                                              kind
                                                                                                              age
                                                                                                              polarity
                                                                                                              not_inferred
                                                                                                              span
                                                                                                              end
                                                                                                              2121
                                                                                                              end exclusive
                                                                                                              true
                                                                                                              exact text
                                                                                                              2 years of age
                                                                                                              label id
                                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                              offset unit
                                                                                                              unicode_code_points
                                                                                                              source array index
                                                                                                              0
                                                                                                              source field
                                                                                                              indications_and_usage_exact
                                                                                                              source text sha256
                                                                                                              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                              start
                                                                                                              2107
                                                                                                            regulatory links
                                                                                                              schema version
                                                                                                              0.1.0
                                                                                                              source batch sha256
                                                                                                              0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                              source defined aliases
                                                                                                                source span
                                                                                                                end
                                                                                                                2132
                                                                                                                end exclusive
                                                                                                                true
                                                                                                                exact text
                                                                                                                1.2 Juvenile Idiopathic Arthritis HYRIMOZ is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older.
                                                                                                                label id
                                                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                offset unit
                                                                                                                unicode_code_points
                                                                                                                source array index
                                                                                                                0
                                                                                                                source field
                                                                                                                indications_and_usage_exact
                                                                                                                source text sha256
                                                                                                                e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                start
                                                                                                                1931
                                                                                                                source url
                                                                                                                https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                spl effective date
                                                                                                                2025-10-17
                                                                                                                spl set id
                                                                                                                3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                spl version
                                                                                                                7
                                                                                                                structured fields status
                                                                                                                not_extracted_no_values_inferred_from_mentions
                                                                                                                structured indication
                                                                                                                age
                                                                                                                Source null
                                                                                                                approval pathway
                                                                                                                Source null
                                                                                                                biomarker and test
                                                                                                                Source null
                                                                                                                disease stage
                                                                                                                Source null
                                                                                                                limitations
                                                                                                                Source null
                                                                                                                line
                                                                                                                Source null
                                                                                                                prior therapy
                                                                                                                Source null
                                                                                                                regimen
                                                                                                                Source null
                                                                                                                tumor histology
                                                                                                                Source null
                                                                                                                use intent
                                                                                                                non_oncology_or_unclear_candidate
                                                                                                                Passage 23 · unclassified context
                                                                                                                application numbers
                                                                                                                1. BLA761071
                                                                                                                brand names
                                                                                                                1. HYRIMOZ
                                                                                                                classification reasons
                                                                                                                1. no_unambiguous_positive_indication_predicate
                                                                                                                clinical review status
                                                                                                                pending
                                                                                                                content role
                                                                                                                unclassified_context
                                                                                                                context span
                                                                                                                end
                                                                                                                2395
                                                                                                                end exclusive
                                                                                                                true
                                                                                                                exact text
                                                                                                                2 Juvenile Idiopathic Arthritis HYRIMOZ is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. HYRIMOZ can be used alone or in combination with methotrexate. 1.3 Psoriatic Arthritis HYRIMOZ is indicated for reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic
                                                                                                                label id
                                                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                offset unit
                                                                                                                unicode_code_points
                                                                                                                source array index
                                                                                                                0
                                                                                                                source field
                                                                                                                indications_and_usage_exact
                                                                                                                source text sha256
                                                                                                                e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                start
                                                                                                                1933
                                                                                                                current approval status
                                                                                                                not_reconciled
                                                                                                                duplicate text group
                                                                                                                dup-68a657120cd47f4582ef
                                                                                                                extraction review status
                                                                                                                automated_candidate_pending_source_review
                                                                                                                generic names
                                                                                                                1. ADALIMUMAB-ADAZ
                                                                                                                id
                                                                                                                ind-span-ef0b00f7364f4fbfb4f7
                                                                                                                label id
                                                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                positive predicate support span
                                                                                                                Source null
                                                                                                                qualifier mentions
                                                                                                                1. context exact
                                                                                                                  HYRIMOZ can be used alone or in combination with methotrexate.
                                                                                                                  kind
                                                                                                                  biomarker
                                                                                                                  polarity
                                                                                                                  not_inferred
                                                                                                                  span
                                                                                                                  end
                                                                                                                  2194
                                                                                                                  end exclusive
                                                                                                                  true
                                                                                                                  exact text
                                                                                                                  methotrexate
                                                                                                                  label id
                                                                                                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                  offset unit
                                                                                                                  unicode_code_points
                                                                                                                  source array index
                                                                                                                  0
                                                                                                                  source field
                                                                                                                  indications_and_usage_exact
                                                                                                                  source text sha256
                                                                                                                  e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                  start
                                                                                                                  2182
                                                                                                                2. context exact
                                                                                                                  HYRIMOZ can be used alone or in combination with methotrexate.
                                                                                                                  kind
                                                                                                                  regimen
                                                                                                                  polarity
                                                                                                                  not_inferred
                                                                                                                  span
                                                                                                                  end
                                                                                                                  2194
                                                                                                                  end exclusive
                                                                                                                  true
                                                                                                                  exact text
                                                                                                                  in combination with methotrexate
                                                                                                                  label id
                                                                                                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                  offset unit
                                                                                                                  unicode_code_points
                                                                                                                  source array index
                                                                                                                  0
                                                                                                                  source field
                                                                                                                  indications_and_usage_exact
                                                                                                                  source text sha256
                                                                                                                  e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                  start
                                                                                                                  2162
                                                                                                                regulatory links
                                                                                                                  schema version
                                                                                                                  0.1.0
                                                                                                                  source batch sha256
                                                                                                                  0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                  source defined aliases
                                                                                                                    source span
                                                                                                                    end
                                                                                                                    2195
                                                                                                                    end exclusive
                                                                                                                    true
                                                                                                                    exact text
                                                                                                                    HYRIMOZ can be used alone or in combination with methotrexate.
                                                                                                                    label id
                                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                    offset unit
                                                                                                                    unicode_code_points
                                                                                                                    source array index
                                                                                                                    0
                                                                                                                    source field
                                                                                                                    indications_and_usage_exact
                                                                                                                    source text sha256
                                                                                                                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                    start
                                                                                                                    2133
                                                                                                                    source url
                                                                                                                    https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                    spl effective date
                                                                                                                    2025-10-17
                                                                                                                    spl set id
                                                                                                                    3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                    spl version
                                                                                                                    7
                                                                                                                    structured fields status
                                                                                                                    not_extracted_no_values_inferred_from_mentions
                                                                                                                    structured indication
                                                                                                                    age
                                                                                                                    Source null
                                                                                                                    approval pathway
                                                                                                                    Source null
                                                                                                                    biomarker and test
                                                                                                                    Source null
                                                                                                                    disease stage
                                                                                                                    Source null
                                                                                                                    limitations
                                                                                                                    Source null
                                                                                                                    line
                                                                                                                    Source null
                                                                                                                    prior therapy
                                                                                                                    Source null
                                                                                                                    regimen
                                                                                                                    Source null
                                                                                                                    tumor histology
                                                                                                                    Source null
                                                                                                                    use intent
                                                                                                                    unclear
                                                                                                                    Passage 24 · positive indication candidate
                                                                                                                    application numbers
                                                                                                                    1. BLA761071
                                                                                                                    brand names
                                                                                                                    1. HYRIMOZ
                                                                                                                    classification reasons
                                                                                                                    1. explicit_positive_indication_predicate
                                                                                                                    2. no_tumor_directed_keyword_in_positive_statement
                                                                                                                    clinical review status
                                                                                                                    pending
                                                                                                                    content role
                                                                                                                    positive_indication_candidate
                                                                                                                    context span
                                                                                                                    end
                                                                                                                    2605
                                                                                                                    end exclusive
                                                                                                                    true
                                                                                                                    exact text
                                                                                                                    ng signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. HYRIMOZ can be used alone or in combination with methotrexate. 1.3 Psoriatic Arthritis HYRIMOZ is indicated for reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis. HYRIMOZ can be used alone or in combination with non-biologic DMARDs. 1.4 Ankylosing Spondylitis HYRIMOZ is indicated for reducing signs and symptoms in adult patients with active ankylosing spondyli
                                                                                                                    label id
                                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                    offset unit
                                                                                                                    unicode_code_points
                                                                                                                    source array index
                                                                                                                    0
                                                                                                                    source field
                                                                                                                    indications_and_usage_exact
                                                                                                                    source text sha256
                                                                                                                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                    start
                                                                                                                    1996
                                                                                                                    current approval status
                                                                                                                    not_reconciled
                                                                                                                    duplicate text group
                                                                                                                    dup-2ffd5bd343242054d075
                                                                                                                    extraction review status
                                                                                                                    automated_candidate_pending_source_review
                                                                                                                    generic names
                                                                                                                    1. ADALIMUMAB-ADAZ
                                                                                                                    id
                                                                                                                    ind-span-d0337d7d8e3a6ff3fd05
                                                                                                                    label id
                                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                    positive predicate support span
                                                                                                                    end
                                                                                                                    2240
                                                                                                                    end exclusive
                                                                                                                    true
                                                                                                                    exact text
                                                                                                                    is indicated
                                                                                                                    label id
                                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                    offset unit
                                                                                                                    unicode_code_points
                                                                                                                    source array index
                                                                                                                    0
                                                                                                                    source field
                                                                                                                    indications_and_usage_exact
                                                                                                                    source text sha256
                                                                                                                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                    start
                                                                                                                    2228
                                                                                                                    qualifier mentions
                                                                                                                    1. context exact
                                                                                                                      on of structural damage, and improving physical function in adult patients with active psoriatic arthritis.
                                                                                                                      kind
                                                                                                                      age
                                                                                                                      polarity
                                                                                                                      not_inferred
                                                                                                                      span
                                                                                                                      end
                                                                                                                      2372
                                                                                                                      end exclusive
                                                                                                                      true
                                                                                                                      exact text
                                                                                                                      adult patients
                                                                                                                      label id
                                                                                                                      04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                      offset unit
                                                                                                                      unicode_code_points
                                                                                                                      source array index
                                                                                                                      0
                                                                                                                      source field
                                                                                                                      indications_and_usage_exact
                                                                                                                      source text sha256
                                                                                                                      e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                      start
                                                                                                                      2358
                                                                                                                    regulatory links
                                                                                                                      schema version
                                                                                                                      0.1.0
                                                                                                                      source batch sha256
                                                                                                                      0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                      source defined aliases
                                                                                                                        source span
                                                                                                                        end
                                                                                                                        2405
                                                                                                                        end exclusive
                                                                                                                        true
                                                                                                                        exact text
                                                                                                                        1.3 Psoriatic Arthritis HYRIMOZ is indicated for reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis.
                                                                                                                        label id
                                                                                                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                        offset unit
                                                                                                                        unicode_code_points
                                                                                                                        source array index
                                                                                                                        0
                                                                                                                        source field
                                                                                                                        indications_and_usage_exact
                                                                                                                        source text sha256
                                                                                                                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                        start
                                                                                                                        2196
                                                                                                                        source url
                                                                                                                        https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                        spl effective date
                                                                                                                        2025-10-17
                                                                                                                        spl set id
                                                                                                                        3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                        spl version
                                                                                                                        7
                                                                                                                        structured fields status
                                                                                                                        not_extracted_no_values_inferred_from_mentions
                                                                                                                        structured indication
                                                                                                                        age
                                                                                                                        Source null
                                                                                                                        approval pathway
                                                                                                                        Source null
                                                                                                                        biomarker and test
                                                                                                                        Source null
                                                                                                                        disease stage
                                                                                                                        Source null
                                                                                                                        limitations
                                                                                                                        Source null
                                                                                                                        line
                                                                                                                        Source null
                                                                                                                        prior therapy
                                                                                                                        Source null
                                                                                                                        regimen
                                                                                                                        Source null
                                                                                                                        tumor histology
                                                                                                                        Source null
                                                                                                                        use intent
                                                                                                                        non_oncology_or_unclear_candidate
                                                                                                                        Passage 25 · unclassified context
                                                                                                                        application numbers
                                                                                                                        1. BLA761071
                                                                                                                        brand names
                                                                                                                        1. HYRIMOZ
                                                                                                                        classification reasons
                                                                                                                        1. no_unambiguous_positive_indication_predicate
                                                                                                                        clinical review status
                                                                                                                        pending
                                                                                                                        content role
                                                                                                                        unclassified_context
                                                                                                                        context span
                                                                                                                        end
                                                                                                                        2675
                                                                                                                        end exclusive
                                                                                                                        true
                                                                                                                        exact text
                                                                                                                        tic Arthritis HYRIMOZ is indicated for reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis. HYRIMOZ can be used alone or in combination with non-biologic DMARDs. 1.4 Ankylosing Spondylitis HYRIMOZ is indicated for reducing signs and symptoms in adult patients with active ankylosing spondylitis. 1.5 Crohn’s Disease HYRIMOZ is indicated for the treatment of mod
                                                                                                                        label id
                                                                                                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                        offset unit
                                                                                                                        unicode_code_points
                                                                                                                        source array index
                                                                                                                        0
                                                                                                                        source field
                                                                                                                        indications_and_usage_exact
                                                                                                                        source text sha256
                                                                                                                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                        start
                                                                                                                        2206
                                                                                                                        current approval status
                                                                                                                        not_reconciled
                                                                                                                        duplicate text group
                                                                                                                        dup-66f63826a776a01b342f
                                                                                                                        extraction review status
                                                                                                                        automated_candidate_pending_source_review
                                                                                                                        generic names
                                                                                                                        1. ADALIMUMAB-ADAZ
                                                                                                                        id
                                                                                                                        ind-span-e0ca5e1dce4af489fd1d
                                                                                                                        label id
                                                                                                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                        positive predicate support span
                                                                                                                        Source null
                                                                                                                        qualifier mentions
                                                                                                                        1. context exact
                                                                                                                          HYRIMOZ can be used alone or in combination with non-biologic DMARDs.
                                                                                                                          kind
                                                                                                                          regimen
                                                                                                                          polarity
                                                                                                                          not_inferred
                                                                                                                          span
                                                                                                                          end
                                                                                                                          2474
                                                                                                                          end exclusive
                                                                                                                          true
                                                                                                                          exact text
                                                                                                                          in combination with non-biologic DMARDs
                                                                                                                          label id
                                                                                                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                          offset unit
                                                                                                                          unicode_code_points
                                                                                                                          source array index
                                                                                                                          0
                                                                                                                          source field
                                                                                                                          indications_and_usage_exact
                                                                                                                          source text sha256
                                                                                                                          e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                          start
                                                                                                                          2435
                                                                                                                        regulatory links
                                                                                                                          schema version
                                                                                                                          0.1.0
                                                                                                                          source batch sha256
                                                                                                                          0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                          source defined aliases
                                                                                                                            source span
                                                                                                                            end
                                                                                                                            2475
                                                                                                                            end exclusive
                                                                                                                            true
                                                                                                                            exact text
                                                                                                                            HYRIMOZ can be used alone or in combination with non-biologic DMARDs.
                                                                                                                            label id
                                                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                            offset unit
                                                                                                                            unicode_code_points
                                                                                                                            source array index
                                                                                                                            0
                                                                                                                            source field
                                                                                                                            indications_and_usage_exact
                                                                                                                            source text sha256
                                                                                                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                            start
                                                                                                                            2406
                                                                                                                            source url
                                                                                                                            https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                            spl effective date
                                                                                                                            2025-10-17
                                                                                                                            spl set id
                                                                                                                            3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                            spl version
                                                                                                                            7
                                                                                                                            structured fields status
                                                                                                                            not_extracted_no_values_inferred_from_mentions
                                                                                                                            structured indication
                                                                                                                            age
                                                                                                                            Source null
                                                                                                                            approval pathway
                                                                                                                            Source null
                                                                                                                            biomarker and test
                                                                                                                            Source null
                                                                                                                            disease stage
                                                                                                                            Source null
                                                                                                                            limitations
                                                                                                                            Source null
                                                                                                                            line
                                                                                                                            Source null
                                                                                                                            prior therapy
                                                                                                                            Source null
                                                                                                                            regimen
                                                                                                                            Source null
                                                                                                                            tumor histology
                                                                                                                            Source null
                                                                                                                            use intent
                                                                                                                            unclear
                                                                                                                            Passage 26 · positive indication candidate
                                                                                                                            application numbers
                                                                                                                            1. BLA761071
                                                                                                                            brand names
                                                                                                                            1. HYRIMOZ
                                                                                                                            classification reasons
                                                                                                                            1. explicit_positive_indication_predicate
                                                                                                                            2. no_tumor_directed_keyword_in_positive_statement
                                                                                                                            clinical review status
                                                                                                                            pending
                                                                                                                            content role
                                                                                                                            positive_indication_candidate
                                                                                                                            context span
                                                                                                                            end
                                                                                                                            2809
                                                                                                                            end exclusive
                                                                                                                            true
                                                                                                                            exact text
                                                                                                                            hibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis. HYRIMOZ can be used alone or in combination with non-biologic DMARDs. 1.4 Ankylosing Spondylitis HYRIMOZ is indicated for reducing signs and symptoms in adult patients with active ankylosing spondylitis. 1.5 Crohn’s Disease HYRIMOZ is indicated for the treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older. 1.6 Ulcerative Colitis HYRIMOZ i
                                                                                                                            label id
                                                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                            offset unit
                                                                                                                            unicode_code_points
                                                                                                                            source array index
                                                                                                                            0
                                                                                                                            source field
                                                                                                                            indications_and_usage_exact
                                                                                                                            source text sha256
                                                                                                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                            start
                                                                                                                            2276
                                                                                                                            current approval status
                                                                                                                            not_reconciled
                                                                                                                            duplicate text group
                                                                                                                            dup-1020a513f13bd55b87ef
                                                                                                                            extraction review status
                                                                                                                            automated_candidate_pending_source_review
                                                                                                                            generic names
                                                                                                                            1. ADALIMUMAB-ADAZ
                                                                                                                            id
                                                                                                                            ind-span-567d3009d7e3f483f7a1
                                                                                                                            label id
                                                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                            positive predicate support span
                                                                                                                            end
                                                                                                                            2523
                                                                                                                            end exclusive
                                                                                                                            true
                                                                                                                            exact text
                                                                                                                            is indicated
                                                                                                                            label id
                                                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                            offset unit
                                                                                                                            unicode_code_points
                                                                                                                            source array index
                                                                                                                            0
                                                                                                                            source field
                                                                                                                            indications_and_usage_exact
                                                                                                                            source text sha256
                                                                                                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                            start
                                                                                                                            2511
                                                                                                                            qualifier mentions
                                                                                                                            1. context exact
                                                                                                                              tis HYRIMOZ is indicated for reducing signs and symptoms in adult patients with active ankylosing spondylitis.
                                                                                                                              kind
                                                                                                                              age
                                                                                                                              polarity
                                                                                                                              not_inferred
                                                                                                                              span
                                                                                                                              end
                                                                                                                              2573
                                                                                                                              end exclusive
                                                                                                                              true
                                                                                                                              exact text
                                                                                                                              adult patients
                                                                                                                              label id
                                                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                              offset unit
                                                                                                                              unicode_code_points
                                                                                                                              source array index
                                                                                                                              0
                                                                                                                              source field
                                                                                                                              indications_and_usage_exact
                                                                                                                              source text sha256
                                                                                                                              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                              start
                                                                                                                              2559
                                                                                                                            regulatory links
                                                                                                                              schema version
                                                                                                                              0.1.0
                                                                                                                              source batch sha256
                                                                                                                              0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                              source defined aliases
                                                                                                                                source span
                                                                                                                                end
                                                                                                                                2609
                                                                                                                                end exclusive
                                                                                                                                true
                                                                                                                                exact text
                                                                                                                                1.4 Ankylosing Spondylitis HYRIMOZ is indicated for reducing signs and symptoms in adult patients with active ankylosing spondylitis.
                                                                                                                                label id
                                                                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                offset unit
                                                                                                                                unicode_code_points
                                                                                                                                source array index
                                                                                                                                0
                                                                                                                                source field
                                                                                                                                indications_and_usage_exact
                                                                                                                                source text sha256
                                                                                                                                e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                start
                                                                                                                                2476
                                                                                                                                source url
                                                                                                                                https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                                spl effective date
                                                                                                                                2025-10-17
                                                                                                                                spl set id
                                                                                                                                3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                                spl version
                                                                                                                                7
                                                                                                                                structured fields status
                                                                                                                                not_extracted_no_values_inferred_from_mentions
                                                                                                                                structured indication
                                                                                                                                age
                                                                                                                                Source null
                                                                                                                                approval pathway
                                                                                                                                Source null
                                                                                                                                biomarker and test
                                                                                                                                Source null
                                                                                                                                disease stage
                                                                                                                                Source null
                                                                                                                                limitations
                                                                                                                                Source null
                                                                                                                                line
                                                                                                                                Source null
                                                                                                                                prior therapy
                                                                                                                                Source null
                                                                                                                                regimen
                                                                                                                                Source null
                                                                                                                                tumor histology
                                                                                                                                Source null
                                                                                                                                use intent
                                                                                                                                non_oncology_or_unclear_candidate
                                                                                                                                Passage 27 · positive indication candidate
                                                                                                                                application numbers
                                                                                                                                1. BLA761071
                                                                                                                                brand names
                                                                                                                                1. HYRIMOZ
                                                                                                                                classification reasons
                                                                                                                                1. explicit_positive_indication_predicate
                                                                                                                                2. no_tumor_directed_keyword_in_positive_statement
                                                                                                                                clinical review status
                                                                                                                                pending
                                                                                                                                content role
                                                                                                                                positive_indication_candidate
                                                                                                                                context span
                                                                                                                                end
                                                                                                                                2976
                                                                                                                                end exclusive
                                                                                                                                true
                                                                                                                                exact text
                                                                                                                                MOZ can be used alone or in combination with non-biologic DMARDs. 1.4 Ankylosing Spondylitis HYRIMOZ is indicated for reducing signs and symptoms in adult patients with active ankylosing spondylitis. 1.5 Crohn’s Disease HYRIMOZ is indicated for the treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older. 1.6 Ulcerative Colitis HYRIMOZ is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: The effectiveness of adalimumab products has n
                                                                                                                                label id
                                                                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                offset unit
                                                                                                                                unicode_code_points
                                                                                                                                source array index
                                                                                                                                0
                                                                                                                                source field
                                                                                                                                indications_and_usage_exact
                                                                                                                                source text sha256
                                                                                                                                e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                start
                                                                                                                                2410
                                                                                                                                current approval status
                                                                                                                                not_reconciled
                                                                                                                                duplicate text group
                                                                                                                                dup-02cae474c08f4f88d404
                                                                                                                                extraction review status
                                                                                                                                automated_candidate_pending_source_review
                                                                                                                                generic names
                                                                                                                                1. ADALIMUMAB-ADAZ
                                                                                                                                id
                                                                                                                                ind-span-74dfac58543b71191b2f
                                                                                                                                label id
                                                                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                positive predicate support span
                                                                                                                                end
                                                                                                                                2650
                                                                                                                                end exclusive
                                                                                                                                true
                                                                                                                                exact text
                                                                                                                                is indicated
                                                                                                                                label id
                                                                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                offset unit
                                                                                                                                unicode_code_points
                                                                                                                                source array index
                                                                                                                                0
                                                                                                                                source field
                                                                                                                                indications_and_usage_exact
                                                                                                                                source text sha256
                                                                                                                                e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                start
                                                                                                                                2638
                                                                                                                                qualifier mentions
                                                                                                                                1. context exact
                                                                                                                                  eatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older.
                                                                                                                                  kind
                                                                                                                                  age
                                                                                                                                  polarity
                                                                                                                                  not_inferred
                                                                                                                                  span
                                                                                                                                  end
                                                                                                                                  2727
                                                                                                                                  end exclusive
                                                                                                                                  true
                                                                                                                                  exact text
                                                                                                                                  adults
                                                                                                                                  label id
                                                                                                                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                  offset unit
                                                                                                                                  unicode_code_points
                                                                                                                                  source array index
                                                                                                                                  0
                                                                                                                                  source field
                                                                                                                                  indications_and_usage_exact
                                                                                                                                  source text sha256
                                                                                                                                  e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                  start
                                                                                                                                  2721
                                                                                                                                2. context exact
                                                                                                                                  moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older.
                                                                                                                                  kind
                                                                                                                                  age
                                                                                                                                  polarity
                                                                                                                                  not_inferred
                                                                                                                                  span
                                                                                                                                  end
                                                                                                                                  2750
                                                                                                                                  end exclusive
                                                                                                                                  true
                                                                                                                                  exact text
                                                                                                                                  pediatric patients
                                                                                                                                  label id
                                                                                                                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                  offset unit
                                                                                                                                  unicode_code_points
                                                                                                                                  source array index
                                                                                                                                  0
                                                                                                                                  source field
                                                                                                                                  indications_and_usage_exact
                                                                                                                                  source text sha256
                                                                                                                                  e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                  start
                                                                                                                                  2732
                                                                                                                                3. context exact
                                                                                                                                  ely active Crohn’s disease in adults and pediatric patients 6 years of age and older.
                                                                                                                                  kind
                                                                                                                                  age
                                                                                                                                  polarity
                                                                                                                                  not_inferred
                                                                                                                                  span
                                                                                                                                  end
                                                                                                                                  2765
                                                                                                                                  end exclusive
                                                                                                                                  true
                                                                                                                                  exact text
                                                                                                                                  6 years of age
                                                                                                                                  label id
                                                                                                                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                  offset unit
                                                                                                                                  unicode_code_points
                                                                                                                                  source array index
                                                                                                                                  0
                                                                                                                                  source field
                                                                                                                                  indications_and_usage_exact
                                                                                                                                  source text sha256
                                                                                                                                  e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                  start
                                                                                                                                  2751
                                                                                                                                regulatory links
                                                                                                                                  schema version
                                                                                                                                  0.1.0
                                                                                                                                  source batch sha256
                                                                                                                                  0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                                  source defined aliases
                                                                                                                                    source span
                                                                                                                                    end
                                                                                                                                    2776
                                                                                                                                    end exclusive
                                                                                                                                    true
                                                                                                                                    exact text
                                                                                                                                    1.5 Crohn’s Disease HYRIMOZ is indicated for the treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older.
                                                                                                                                    label id
                                                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                    offset unit
                                                                                                                                    unicode_code_points
                                                                                                                                    source array index
                                                                                                                                    0
                                                                                                                                    source field
                                                                                                                                    indications_and_usage_exact
                                                                                                                                    source text sha256
                                                                                                                                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                    start
                                                                                                                                    2610
                                                                                                                                    source url
                                                                                                                                    https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                                    spl effective date
                                                                                                                                    2025-10-17
                                                                                                                                    spl set id
                                                                                                                                    3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                                    spl version
                                                                                                                                    7
                                                                                                                                    structured fields status
                                                                                                                                    not_extracted_no_values_inferred_from_mentions
                                                                                                                                    structured indication
                                                                                                                                    age
                                                                                                                                    Source null
                                                                                                                                    approval pathway
                                                                                                                                    Source null
                                                                                                                                    biomarker and test
                                                                                                                                    Source null
                                                                                                                                    disease stage
                                                                                                                                    Source null
                                                                                                                                    limitations
                                                                                                                                    Source null
                                                                                                                                    line
                                                                                                                                    Source null
                                                                                                                                    prior therapy
                                                                                                                                    Source null
                                                                                                                                    regimen
                                                                                                                                    Source null
                                                                                                                                    tumor histology
                                                                                                                                    Source null
                                                                                                                                    use intent
                                                                                                                                    non_oncology_or_unclear_candidate
                                                                                                                                    Passage 28 · positive indication candidate
                                                                                                                                    application numbers
                                                                                                                                    1. BLA761071
                                                                                                                                    brand names
                                                                                                                                    1. HYRIMOZ
                                                                                                                                    classification reasons
                                                                                                                                    1. explicit_positive_indication_predicate
                                                                                                                                    2. no_tumor_directed_keyword_in_positive_statement
                                                                                                                                    clinical review status
                                                                                                                                    pending
                                                                                                                                    content role
                                                                                                                                    positive_indication_candidate
                                                                                                                                    context span
                                                                                                                                    end
                                                                                                                                    3109
                                                                                                                                    end exclusive
                                                                                                                                    true
                                                                                                                                    exact text
                                                                                                                                    h active ankylosing spondylitis. 1.5 Crohn’s Disease HYRIMOZ is indicated for the treatment of moderately to severely active Crohn’s disease in adults and pediatric patients 6 years of age and older. 1.6 Ulcerative Colitis HYRIMOZ is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: The effectiveness of adalimumab products has not been established in patients who have lost response to or were intolerant to TNF-blockers [see Clinical Studies (14.7) ] . 1.7 Pla
                                                                                                                                    label id
                                                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                    offset unit
                                                                                                                                    unicode_code_points
                                                                                                                                    source array index
                                                                                                                                    0
                                                                                                                                    source field
                                                                                                                                    indications_and_usage_exact
                                                                                                                                    source text sha256
                                                                                                                                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                    start
                                                                                                                                    2577
                                                                                                                                    current approval status
                                                                                                                                    not_reconciled
                                                                                                                                    duplicate text group
                                                                                                                                    dup-b2815cc7b90fb6f45610
                                                                                                                                    extraction review status
                                                                                                                                    automated_candidate_pending_source_review
                                                                                                                                    generic names
                                                                                                                                    1. ADALIMUMAB-ADAZ
                                                                                                                                    id
                                                                                                                                    ind-span-2a2ff8dcf57bcd24d834
                                                                                                                                    label id
                                                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                    positive predicate support span
                                                                                                                                    end
                                                                                                                                    2820
                                                                                                                                    end exclusive
                                                                                                                                    true
                                                                                                                                    exact text
                                                                                                                                    is indicated
                                                                                                                                    label id
                                                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                    offset unit
                                                                                                                                    unicode_code_points
                                                                                                                                    source array index
                                                                                                                                    0
                                                                                                                                    source field
                                                                                                                                    indications_and_usage_exact
                                                                                                                                    source text sha256
                                                                                                                                    e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                    start
                                                                                                                                    2808
                                                                                                                                    qualifier mentions
                                                                                                                                    1. context exact
                                                                                                                                      ment of moderately to severely active ulcerative colitis in adult patients.
                                                                                                                                      kind
                                                                                                                                      age
                                                                                                                                      polarity
                                                                                                                                      not_inferred
                                                                                                                                      span
                                                                                                                                      end
                                                                                                                                      2908
                                                                                                                                      end exclusive
                                                                                                                                      true
                                                                                                                                      exact text
                                                                                                                                      adult patients
                                                                                                                                      label id
                                                                                                                                      04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                      offset unit
                                                                                                                                      unicode_code_points
                                                                                                                                      source array index
                                                                                                                                      0
                                                                                                                                      source field
                                                                                                                                      indications_and_usage_exact
                                                                                                                                      source text sha256
                                                                                                                                      e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                      start
                                                                                                                                      2894
                                                                                                                                    regulatory links
                                                                                                                                      schema version
                                                                                                                                      0.1.0
                                                                                                                                      source batch sha256
                                                                                                                                      0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                                      source defined aliases
                                                                                                                                        source span
                                                                                                                                        end
                                                                                                                                        2909
                                                                                                                                        end exclusive
                                                                                                                                        true
                                                                                                                                        exact text
                                                                                                                                        1.6 Ulcerative Colitis HYRIMOZ is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients.
                                                                                                                                        label id
                                                                                                                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                        offset unit
                                                                                                                                        unicode_code_points
                                                                                                                                        source array index
                                                                                                                                        0
                                                                                                                                        source field
                                                                                                                                        indications_and_usage_exact
                                                                                                                                        source text sha256
                                                                                                                                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                        start
                                                                                                                                        2777
                                                                                                                                        source url
                                                                                                                                        https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                                        spl effective date
                                                                                                                                        2025-10-17
                                                                                                                                        spl set id
                                                                                                                                        3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                                        spl version
                                                                                                                                        7
                                                                                                                                        structured fields status
                                                                                                                                        not_extracted_no_values_inferred_from_mentions
                                                                                                                                        structured indication
                                                                                                                                        age
                                                                                                                                        Source null
                                                                                                                                        approval pathway
                                                                                                                                        Source null
                                                                                                                                        biomarker and test
                                                                                                                                        Source null
                                                                                                                                        disease stage
                                                                                                                                        Source null
                                                                                                                                        limitations
                                                                                                                                        Source null
                                                                                                                                        line
                                                                                                                                        Source null
                                                                                                                                        prior therapy
                                                                                                                                        Source null
                                                                                                                                        regimen
                                                                                                                                        Source null
                                                                                                                                        tumor histology
                                                                                                                                        Source null
                                                                                                                                        use intent
                                                                                                                                        non_oncology_or_unclear_candidate
                                                                                                                                        Passage 29 · limitation of use
                                                                                                                                        application numbers
                                                                                                                                        1. BLA761071
                                                                                                                                        brand names
                                                                                                                                        1. HYRIMOZ
                                                                                                                                        classification reasons
                                                                                                                                        1. negative_or_not_established_clause
                                                                                                                                        clinical review status
                                                                                                                                        pending
                                                                                                                                        content role
                                                                                                                                        limitation_of_use
                                                                                                                                        context span
                                                                                                                                        end
                                                                                                                                        3301
                                                                                                                                        end exclusive
                                                                                                                                        true
                                                                                                                                        exact text
                                                                                                                                        disease in adults and pediatric patients 6 years of age and older. 1.6 Ulcerative Colitis HYRIMOZ is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: The effectiveness of adalimumab products has not been established in patients who have lost response to or were intolerant to TNF-blockers [see Clinical Studies (14.7) ] . 1.7 Plaque Psoriasis HYRIMOZ is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other
                                                                                                                                        label id
                                                                                                                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                        offset unit
                                                                                                                                        unicode_code_points
                                                                                                                                        source array index
                                                                                                                                        0
                                                                                                                                        source field
                                                                                                                                        indications_and_usage_exact
                                                                                                                                        source text sha256
                                                                                                                                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                        start
                                                                                                                                        2710
                                                                                                                                        current approval status
                                                                                                                                        not_reconciled
                                                                                                                                        duplicate text group
                                                                                                                                        dup-e99e298aeba9667e586c
                                                                                                                                        extraction review status
                                                                                                                                        automated_candidate_pending_source_review
                                                                                                                                        generic names
                                                                                                                                        1. ADALIMUMAB-ADAZ
                                                                                                                                        id
                                                                                                                                        ind-span-b03c9ca987b2b9d75ed0
                                                                                                                                        label id
                                                                                                                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                        positive predicate support span
                                                                                                                                        Source null
                                                                                                                                        qualifier mentions
                                                                                                                                          regulatory links
                                                                                                                                            schema version
                                                                                                                                            0.1.0
                                                                                                                                            source batch sha256
                                                                                                                                            0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                                            source defined aliases
                                                                                                                                              source span
                                                                                                                                              end
                                                                                                                                              3101
                                                                                                                                              end exclusive
                                                                                                                                              true
                                                                                                                                              exact text
                                                                                                                                              Limitations of Use: The effectiveness of adalimumab products has not been established in patients who have lost response to or were intolerant to TNF-blockers [see Clinical Studies (14.7) ] .
                                                                                                                                              label id
                                                                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                              offset unit
                                                                                                                                              unicode_code_points
                                                                                                                                              source array index
                                                                                                                                              0
                                                                                                                                              source field
                                                                                                                                              indications_and_usage_exact
                                                                                                                                              source text sha256
                                                                                                                                              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                              start
                                                                                                                                              2910
                                                                                                                                              source url
                                                                                                                                              https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                                              spl effective date
                                                                                                                                              2025-10-17
                                                                                                                                              spl set id
                                                                                                                                              3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                                              spl version
                                                                                                                                              7
                                                                                                                                              structured fields status
                                                                                                                                              not_extracted_no_values_inferred_from_mentions
                                                                                                                                              structured indication
                                                                                                                                              age
                                                                                                                                              Source null
                                                                                                                                              approval pathway
                                                                                                                                              Source null
                                                                                                                                              biomarker and test
                                                                                                                                              Source null
                                                                                                                                              disease stage
                                                                                                                                              Source null
                                                                                                                                              limitations
                                                                                                                                              Source null
                                                                                                                                              line
                                                                                                                                              Source null
                                                                                                                                              prior therapy
                                                                                                                                              Source null
                                                                                                                                              regimen
                                                                                                                                              Source null
                                                                                                                                              tumor histology
                                                                                                                                              Source null
                                                                                                                                              use intent
                                                                                                                                              not_applicable
                                                                                                                                              Passage 30 · positive indication candidate
                                                                                                                                              application numbers
                                                                                                                                              1. BLA761071
                                                                                                                                              brand names
                                                                                                                                              1. HYRIMOZ
                                                                                                                                              classification reasons
                                                                                                                                              1. explicit_positive_indication_predicate
                                                                                                                                              2. no_tumor_directed_keyword_in_positive_statement
                                                                                                                                              clinical review status
                                                                                                                                              pending
                                                                                                                                              content role
                                                                                                                                              positive_indication_candidate
                                                                                                                                              context span
                                                                                                                                              end
                                                                                                                                              3551
                                                                                                                                              end exclusive
                                                                                                                                              true
                                                                                                                                              exact text
                                                                                                                                              tients. Limitations of Use: The effectiveness of adalimumab products has not been established in patients who have lost response to or were intolerant to TNF-blockers [see Clinical Studies (14.7) ] . 1.7 Plaque Psoriasis HYRIMOZ is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. HYRIMOZ should only be administered to patients who will be closely monitored and have regular follow-up visits with a physician [see Warnings and Precautions (5) ] . 1.8 Hidradenitis Suppurativa HYR
                                                                                                                                              label id
                                                                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                              offset unit
                                                                                                                                              unicode_code_points
                                                                                                                                              source array index
                                                                                                                                              0
                                                                                                                                              source field
                                                                                                                                              indications_and_usage_exact
                                                                                                                                              source text sha256
                                                                                                                                              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                              start
                                                                                                                                              2902
                                                                                                                                              current approval status
                                                                                                                                              not_reconciled
                                                                                                                                              duplicate text group
                                                                                                                                              dup-c878ad80c94005d8c69f
                                                                                                                                              extraction review status
                                                                                                                                              automated_candidate_pending_source_review
                                                                                                                                              generic names
                                                                                                                                              1. ADALIMUMAB-ADAZ
                                                                                                                                              id
                                                                                                                                              ind-span-1ecd1970c57519b2d812
                                                                                                                                              label id
                                                                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                              positive predicate support span
                                                                                                                                              end
                                                                                                                                              3143
                                                                                                                                              end exclusive
                                                                                                                                              true
                                                                                                                                              exact text
                                                                                                                                              is indicated
                                                                                                                                              label id
                                                                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                              offset unit
                                                                                                                                              unicode_code_points
                                                                                                                                              source array index
                                                                                                                                              0
                                                                                                                                              source field
                                                                                                                                              indications_and_usage_exact
                                                                                                                                              source text sha256
                                                                                                                                              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                              start
                                                                                                                                              3131
                                                                                                                                              qualifier mentions
                                                                                                                                              1. context exact
                                                                                                                                                Plaque Psoriasis HYRIMOZ is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are ca
                                                                                                                                                kind
                                                                                                                                                age
                                                                                                                                                polarity
                                                                                                                                                not_inferred
                                                                                                                                                span
                                                                                                                                                end
                                                                                                                                                3179
                                                                                                                                                end exclusive
                                                                                                                                                true
                                                                                                                                                exact text
                                                                                                                                                adult patients
                                                                                                                                                label id
                                                                                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                offset unit
                                                                                                                                                unicode_code_points
                                                                                                                                                source array index
                                                                                                                                                0
                                                                                                                                                source field
                                                                                                                                                indications_and_usage_exact
                                                                                                                                                source text sha256
                                                                                                                                                e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                                start
                                                                                                                                                3165
                                                                                                                                              regulatory links
                                                                                                                                                schema version
                                                                                                                                                0.1.0
                                                                                                                                                source batch sha256
                                                                                                                                                0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                                                source defined aliases
                                                                                                                                                  source span
                                                                                                                                                  end
                                                                                                                                                  3351
                                                                                                                                                  end exclusive
                                                                                                                                                  true
                                                                                                                                                  exact text
                                                                                                                                                  1.7 Plaque Psoriasis HYRIMOZ is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
                                                                                                                                                  label id
                                                                                                                                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                  offset unit
                                                                                                                                                  unicode_code_points
                                                                                                                                                  source array index
                                                                                                                                                  0
                                                                                                                                                  source field
                                                                                                                                                  indications_and_usage_exact
                                                                                                                                                  source text sha256
                                                                                                                                                  e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                                  start
                                                                                                                                                  3102
                                                                                                                                                  source url
                                                                                                                                                  https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                                                  spl effective date
                                                                                                                                                  2025-10-17
                                                                                                                                                  spl set id
                                                                                                                                                  3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                                                  spl version
                                                                                                                                                  7
                                                                                                                                                  structured fields status
                                                                                                                                                  not_extracted_no_values_inferred_from_mentions
                                                                                                                                                  structured indication
                                                                                                                                                  age
                                                                                                                                                  Source null
                                                                                                                                                  approval pathway
                                                                                                                                                  Source null
                                                                                                                                                  biomarker and test
                                                                                                                                                  Source null
                                                                                                                                                  disease stage
                                                                                                                                                  Source null
                                                                                                                                                  limitations
                                                                                                                                                  Source null
                                                                                                                                                  line
                                                                                                                                                  Source null
                                                                                                                                                  prior therapy
                                                                                                                                                  Source null
                                                                                                                                                  regimen
                                                                                                                                                  Source null
                                                                                                                                                  tumor histology
                                                                                                                                                  Source null
                                                                                                                                                  use intent
                                                                                                                                                  non_oncology_or_unclear_candidate
                                                                                                                                                  Passage 31 · risk or warning
                                                                                                                                                  application numbers
                                                                                                                                                  1. BLA761071
                                                                                                                                                  brand names
                                                                                                                                                  1. HYRIMOZ
                                                                                                                                                  classification reasons
                                                                                                                                                  1. risk_or_warning_words_without_positive_predicate
                                                                                                                                                  clinical review status
                                                                                                                                                  pending
                                                                                                                                                  content role
                                                                                                                                                  risk_or_warning
                                                                                                                                                  context span
                                                                                                                                                  end
                                                                                                                                                  3718
                                                                                                                                                  end exclusive
                                                                                                                                                  true
                                                                                                                                                  exact text
                                                                                                                                                  treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. HYRIMOZ should only be administered to patients who will be closely monitored and have regular follow-up visits with a physician [see Warnings and Precautions (5) ] . 1.8 Hidradenitis Suppurativa HYRIMOZ is indicated for the treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older. 1.9 Uveitis HYRIMOZ is indicated for the trea
                                                                                                                                                  label id
                                                                                                                                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                  offset unit
                                                                                                                                                  unicode_code_points
                                                                                                                                                  source array index
                                                                                                                                                  0
                                                                                                                                                  source field
                                                                                                                                                  indications_and_usage_exact
                                                                                                                                                  source text sha256
                                                                                                                                                  e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                                  start
                                                                                                                                                  3152
                                                                                                                                                  current approval status
                                                                                                                                                  not_reconciled
                                                                                                                                                  duplicate text group
                                                                                                                                                  dup-2d77db92632a9b459a6e
                                                                                                                                                  extraction review status
                                                                                                                                                  automated_candidate_pending_source_review
                                                                                                                                                  generic names
                                                                                                                                                  1. ADALIMUMAB-ADAZ
                                                                                                                                                  id
                                                                                                                                                  ind-span-003d45e220d82e2477e6
                                                                                                                                                  label id
                                                                                                                                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                  positive predicate support span
                                                                                                                                                  Source null
                                                                                                                                                  qualifier mentions
                                                                                                                                                    regulatory links
                                                                                                                                                      schema version
                                                                                                                                                      0.1.0
                                                                                                                                                      source batch sha256
                                                                                                                                                      0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                                                      source defined aliases
                                                                                                                                                        source span
                                                                                                                                                        end
                                                                                                                                                        3518
                                                                                                                                                        end exclusive
                                                                                                                                                        true
                                                                                                                                                        exact text
                                                                                                                                                        HYRIMOZ should only be administered to patients who will be closely monitored and have regular follow-up visits with a physician [see Warnings and Precautions (5) ] .
                                                                                                                                                        label id
                                                                                                                                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                        offset unit
                                                                                                                                                        unicode_code_points
                                                                                                                                                        source array index
                                                                                                                                                        0
                                                                                                                                                        source field
                                                                                                                                                        indications_and_usage_exact
                                                                                                                                                        source text sha256
                                                                                                                                                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                                        start
                                                                                                                                                        3352
                                                                                                                                                        source url
                                                                                                                                                        https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                                                        spl effective date
                                                                                                                                                        2025-10-17
                                                                                                                                                        spl set id
                                                                                                                                                        3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                                                        spl version
                                                                                                                                                        7
                                                                                                                                                        structured fields status
                                                                                                                                                        not_extracted_no_values_inferred_from_mentions
                                                                                                                                                        structured indication
                                                                                                                                                        age
                                                                                                                                                        Source null
                                                                                                                                                        approval pathway
                                                                                                                                                        Source null
                                                                                                                                                        biomarker and test
                                                                                                                                                        Source null
                                                                                                                                                        disease stage
                                                                                                                                                        Source null
                                                                                                                                                        limitations
                                                                                                                                                        Source null
                                                                                                                                                        line
                                                                                                                                                        Source null
                                                                                                                                                        prior therapy
                                                                                                                                                        Source null
                                                                                                                                                        regimen
                                                                                                                                                        Source null
                                                                                                                                                        tumor histology
                                                                                                                                                        Source null
                                                                                                                                                        use intent
                                                                                                                                                        not_applicable
                                                                                                                                                        Passage 32 · positive indication candidate
                                                                                                                                                        application numbers
                                                                                                                                                        1. BLA761071
                                                                                                                                                        brand names
                                                                                                                                                        1. HYRIMOZ
                                                                                                                                                        classification reasons
                                                                                                                                                        1. explicit_positive_indication_predicate
                                                                                                                                                        2. no_tumor_directed_keyword_in_positive_statement
                                                                                                                                                        clinical review status
                                                                                                                                                        pending
                                                                                                                                                        content role
                                                                                                                                                        positive_indication_candidate
                                                                                                                                                        context span
                                                                                                                                                        end
                                                                                                                                                        3840
                                                                                                                                                        end exclusive
                                                                                                                                                        true
                                                                                                                                                        exact text
                                                                                                                                                        are medically less appropriate. HYRIMOZ should only be administered to patients who will be closely monitored and have regular follow-up visits with a physician [see Warnings and Precautions (5) ] . 1.8 Hidradenitis Suppurativa HYRIMOZ is indicated for the treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older. 1.9 Uveitis HYRIMOZ is indicated for the treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.
                                                                                                                                                        label id
                                                                                                                                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                        offset unit
                                                                                                                                                        unicode_code_points
                                                                                                                                                        source array index
                                                                                                                                                        0
                                                                                                                                                        source field
                                                                                                                                                        indications_and_usage_exact
                                                                                                                                                        source text sha256
                                                                                                                                                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                                        start
                                                                                                                                                        3319
                                                                                                                                                        current approval status
                                                                                                                                                        not_reconciled
                                                                                                                                                        duplicate text group
                                                                                                                                                        dup-01e055e55fe1ebff6bbc
                                                                                                                                                        extraction review status
                                                                                                                                                        automated_candidate_pending_source_review
                                                                                                                                                        generic names
                                                                                                                                                        1. ADALIMUMAB-ADAZ
                                                                                                                                                        id
                                                                                                                                                        ind-span-638ef1fc3f2fb3919f2c
                                                                                                                                                        label id
                                                                                                                                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                        positive predicate support span
                                                                                                                                                        end
                                                                                                                                                        3568
                                                                                                                                                        end exclusive
                                                                                                                                                        true
                                                                                                                                                        exact text
                                                                                                                                                        is indicated
                                                                                                                                                        label id
                                                                                                                                                        04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                        offset unit
                                                                                                                                                        unicode_code_points
                                                                                                                                                        source array index
                                                                                                                                                        0
                                                                                                                                                        source field
                                                                                                                                                        indications_and_usage_exact
                                                                                                                                                        source text sha256
                                                                                                                                                        e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                                        start
                                                                                                                                                        3556
                                                                                                                                                        qualifier mentions
                                                                                                                                                        1. context exact
                                                                                                                                                          of moderate to severe hidradenitis suppurativa in patients 12 years of age and older.
                                                                                                                                                          kind
                                                                                                                                                          age
                                                                                                                                                          polarity
                                                                                                                                                          not_inferred
                                                                                                                                                          span
                                                                                                                                                          end
                                                                                                                                                          3661
                                                                                                                                                          end exclusive
                                                                                                                                                          true
                                                                                                                                                          exact text
                                                                                                                                                          12 years of age
                                                                                                                                                          label id
                                                                                                                                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                          offset unit
                                                                                                                                                          unicode_code_points
                                                                                                                                                          source array index
                                                                                                                                                          0
                                                                                                                                                          source field
                                                                                                                                                          indications_and_usage_exact
                                                                                                                                                          source text sha256
                                                                                                                                                          e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                                          start
                                                                                                                                                          3646
                                                                                                                                                        regulatory links
                                                                                                                                                          schema version
                                                                                                                                                          0.1.0
                                                                                                                                                          source batch sha256
                                                                                                                                                          0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                                                          source defined aliases
                                                                                                                                                            source span
                                                                                                                                                            end
                                                                                                                                                            3672
                                                                                                                                                            end exclusive
                                                                                                                                                            true
                                                                                                                                                            exact text
                                                                                                                                                            1.8 Hidradenitis Suppurativa HYRIMOZ is indicated for the treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older.
                                                                                                                                                            label id
                                                                                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                            offset unit
                                                                                                                                                            unicode_code_points
                                                                                                                                                            source array index
                                                                                                                                                            0
                                                                                                                                                            source field
                                                                                                                                                            indications_and_usage_exact
                                                                                                                                                            source text sha256
                                                                                                                                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                                            start
                                                                                                                                                            3519
                                                                                                                                                            source url
                                                                                                                                                            https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                                                            spl effective date
                                                                                                                                                            2025-10-17
                                                                                                                                                            spl set id
                                                                                                                                                            3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                                                            spl version
                                                                                                                                                            7
                                                                                                                                                            structured fields status
                                                                                                                                                            not_extracted_no_values_inferred_from_mentions
                                                                                                                                                            structured indication
                                                                                                                                                            age
                                                                                                                                                            Source null
                                                                                                                                                            approval pathway
                                                                                                                                                            Source null
                                                                                                                                                            biomarker and test
                                                                                                                                                            Source null
                                                                                                                                                            disease stage
                                                                                                                                                            Source null
                                                                                                                                                            limitations
                                                                                                                                                            Source null
                                                                                                                                                            line
                                                                                                                                                            Source null
                                                                                                                                                            prior therapy
                                                                                                                                                            Source null
                                                                                                                                                            regimen
                                                                                                                                                            Source null
                                                                                                                                                            tumor histology
                                                                                                                                                            Source null
                                                                                                                                                            use intent
                                                                                                                                                            non_oncology_or_unclear_candidate
                                                                                                                                                            Passage 33 · positive indication candidate
                                                                                                                                                            application numbers
                                                                                                                                                            1. BLA761071
                                                                                                                                                            brand names
                                                                                                                                                            1. HYRIMOZ
                                                                                                                                                            classification reasons
                                                                                                                                                            1. explicit_positive_indication_predicate
                                                                                                                                                            2. no_tumor_directed_keyword_in_positive_statement
                                                                                                                                                            clinical review status
                                                                                                                                                            pending
                                                                                                                                                            content role
                                                                                                                                                            positive_indication_candidate
                                                                                                                                                            context span
                                                                                                                                                            end
                                                                                                                                                            3840
                                                                                                                                                            end exclusive
                                                                                                                                                            true
                                                                                                                                                            exact text
                                                                                                                                                            ysician [see Warnings and Precautions (5) ] . 1.8 Hidradenitis Suppurativa HYRIMOZ is indicated for the treatment of moderate to severe hidradenitis suppurativa in patients 12 years of age and older. 1.9 Uveitis HYRIMOZ is indicated for the treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.
                                                                                                                                                            label id
                                                                                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                            offset unit
                                                                                                                                                            unicode_code_points
                                                                                                                                                            source array index
                                                                                                                                                            0
                                                                                                                                                            source field
                                                                                                                                                            indications_and_usage_exact
                                                                                                                                                            source text sha256
                                                                                                                                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                                            start
                                                                                                                                                            3473
                                                                                                                                                            current approval status
                                                                                                                                                            not_reconciled
                                                                                                                                                            duplicate text group
                                                                                                                                                            dup-5a3d3145a3a76151ef1c
                                                                                                                                                            extraction review status
                                                                                                                                                            automated_candidate_pending_source_review
                                                                                                                                                            generic names
                                                                                                                                                            1. ADALIMUMAB-ADAZ
                                                                                                                                                            id
                                                                                                                                                            ind-span-4fd6536c6f72e193585d
                                                                                                                                                            label id
                                                                                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                            positive predicate support span
                                                                                                                                                            end
                                                                                                                                                            3705
                                                                                                                                                            end exclusive
                                                                                                                                                            true
                                                                                                                                                            exact text
                                                                                                                                                            is indicated
                                                                                                                                                            label id
                                                                                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                            offset unit
                                                                                                                                                            unicode_code_points
                                                                                                                                                            source array index
                                                                                                                                                            0
                                                                                                                                                            source field
                                                                                                                                                            indications_and_usage_exact
                                                                                                                                                            source text sha256
                                                                                                                                                            e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                                            start
                                                                                                                                                            3693
                                                                                                                                                            qualifier mentions
                                                                                                                                                            1. context exact
                                                                                                                                                              f non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.
                                                                                                                                                              kind
                                                                                                                                                              age
                                                                                                                                                              polarity
                                                                                                                                                              not_inferred
                                                                                                                                                              span
                                                                                                                                                              end
                                                                                                                                                              3791
                                                                                                                                                              end exclusive
                                                                                                                                                              true
                                                                                                                                                              exact text
                                                                                                                                                              adults
                                                                                                                                                              label id
                                                                                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                              offset unit
                                                                                                                                                              unicode_code_points
                                                                                                                                                              source array index
                                                                                                                                                              0
                                                                                                                                                              source field
                                                                                                                                                              indications_and_usage_exact
                                                                                                                                                              source text sha256
                                                                                                                                                              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                                              start
                                                                                                                                                              3785
                                                                                                                                                            2. context exact
                                                                                                                                                              tious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.
                                                                                                                                                              kind
                                                                                                                                                              age
                                                                                                                                                              polarity
                                                                                                                                                              not_inferred
                                                                                                                                                              span
                                                                                                                                                              end
                                                                                                                                                              3814
                                                                                                                                                              end exclusive
                                                                                                                                                              true
                                                                                                                                                              exact text
                                                                                                                                                              pediatric patients
                                                                                                                                                              label id
                                                                                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                              offset unit
                                                                                                                                                              unicode_code_points
                                                                                                                                                              source array index
                                                                                                                                                              0
                                                                                                                                                              source field
                                                                                                                                                              indications_and_usage_exact
                                                                                                                                                              source text sha256
                                                                                                                                                              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                                              start
                                                                                                                                                              3796
                                                                                                                                                            3. context exact
                                                                                                                                                              posterior, and panuveitis in adults and pediatric patients 2 years of age and older.
                                                                                                                                                              kind
                                                                                                                                                              age
                                                                                                                                                              polarity
                                                                                                                                                              not_inferred
                                                                                                                                                              span
                                                                                                                                                              end
                                                                                                                                                              3829
                                                                                                                                                              end exclusive
                                                                                                                                                              true
                                                                                                                                                              exact text
                                                                                                                                                              2 years of age
                                                                                                                                                              label id
                                                                                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                              offset unit
                                                                                                                                                              unicode_code_points
                                                                                                                                                              source array index
                                                                                                                                                              0
                                                                                                                                                              source field
                                                                                                                                                              indications_and_usage_exact
                                                                                                                                                              source text sha256
                                                                                                                                                              e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                                              start
                                                                                                                                                              3815
                                                                                                                                                            regulatory links
                                                                                                                                                              schema version
                                                                                                                                                              0.1.0
                                                                                                                                                              source batch sha256
                                                                                                                                                              0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                                                              source defined aliases
                                                                                                                                                                source span
                                                                                                                                                                end
                                                                                                                                                                3840
                                                                                                                                                                end exclusive
                                                                                                                                                                true
                                                                                                                                                                exact text
                                                                                                                                                                1.9 Uveitis HYRIMOZ is indicated for the treatment of non-infectious intermediate, posterior, and panuveitis in adults and pediatric patients 2 years of age and older.
                                                                                                                                                                label id
                                                                                                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                offset unit
                                                                                                                                                                unicode_code_points
                                                                                                                                                                source array index
                                                                                                                                                                0
                                                                                                                                                                source field
                                                                                                                                                                indications_and_usage_exact
                                                                                                                                                                source text sha256
                                                                                                                                                                e47f2d585a7ca43172a4cffbe273364ab111a9835f9e87a8fa50b1dbe1413580
                                                                                                                                                                start
                                                                                                                                                                3673
                                                                                                                                                                source url
                                                                                                                                                                https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                                                                spl effective date
                                                                                                                                                                2025-10-17
                                                                                                                                                                spl set id
                                                                                                                                                                3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                                                                spl version
                                                                                                                                                                7
                                                                                                                                                                structured fields status
                                                                                                                                                                not_extracted_no_values_inferred_from_mentions
                                                                                                                                                                structured indication
                                                                                                                                                                age
                                                                                                                                                                Source null
                                                                                                                                                                approval pathway
                                                                                                                                                                Source null
                                                                                                                                                                biomarker and test
                                                                                                                                                                Source null
                                                                                                                                                                disease stage
                                                                                                                                                                Source null
                                                                                                                                                                limitations
                                                                                                                                                                Source null
                                                                                                                                                                line
                                                                                                                                                                Source null
                                                                                                                                                                prior therapy
                                                                                                                                                                Source null
                                                                                                                                                                regimen
                                                                                                                                                                Source null
                                                                                                                                                                tumor histology
                                                                                                                                                                Source null
                                                                                                                                                                use intent
                                                                                                                                                                non_oncology_or_unclear_candidate
                                                                                                                                                                Passage 34 · positive indication candidate
                                                                                                                                                                application numbers
                                                                                                                                                                1. BLA761071
                                                                                                                                                                brand names
                                                                                                                                                                1. HYRIMOZ
                                                                                                                                                                classification reasons
                                                                                                                                                                1. explicit_positive_indication_predicate
                                                                                                                                                                2. no_tumor_directed_keyword_in_positive_statement
                                                                                                                                                                clinical review status
                                                                                                                                                                pending
                                                                                                                                                                content role
                                                                                                                                                                positive_indication_candidate
                                                                                                                                                                context span
                                                                                                                                                                end
                                                                                                                                                                324
                                                                                                                                                                end exclusive
                                                                                                                                                                true
                                                                                                                                                                exact text
                                                                                                                                                                1.6 Ulcerative Colitis HYRIMOZ is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: The effectiveness of adalimumab products has not been established in patients who have lost response to or were intolerant to TNF-blockers [see Clinical Studies (14.7) ] .
                                                                                                                                                                label id
                                                                                                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                offset unit
                                                                                                                                                                unicode_code_points
                                                                                                                                                                source array index
                                                                                                                                                                1
                                                                                                                                                                source field
                                                                                                                                                                indications_and_usage_exact
                                                                                                                                                                source text sha256
                                                                                                                                                                79e546a86a581105faf4e6a070d201795a61db0f641d00f790c1276d6bac893c
                                                                                                                                                                start
                                                                                                                                                                0
                                                                                                                                                                current approval status
                                                                                                                                                                not_reconciled
                                                                                                                                                                duplicate text group
                                                                                                                                                                dup-b2815cc7b90fb6f45610
                                                                                                                                                                extraction review status
                                                                                                                                                                automated_candidate_pending_source_review
                                                                                                                                                                generic names
                                                                                                                                                                1. ADALIMUMAB-ADAZ
                                                                                                                                                                id
                                                                                                                                                                ind-span-1377934c89a42cc23cc1
                                                                                                                                                                label id
                                                                                                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                positive predicate support span
                                                                                                                                                                end
                                                                                                                                                                43
                                                                                                                                                                end exclusive
                                                                                                                                                                true
                                                                                                                                                                exact text
                                                                                                                                                                is indicated
                                                                                                                                                                label id
                                                                                                                                                                04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                offset unit
                                                                                                                                                                unicode_code_points
                                                                                                                                                                source array index
                                                                                                                                                                1
                                                                                                                                                                source field
                                                                                                                                                                indications_and_usage_exact
                                                                                                                                                                source text sha256
                                                                                                                                                                79e546a86a581105faf4e6a070d201795a61db0f641d00f790c1276d6bac893c
                                                                                                                                                                start
                                                                                                                                                                31
                                                                                                                                                                qualifier mentions
                                                                                                                                                                1. context exact
                                                                                                                                                                  ment of moderately to severely active ulcerative colitis in adult patients.
                                                                                                                                                                  kind
                                                                                                                                                                  age
                                                                                                                                                                  polarity
                                                                                                                                                                  not_inferred
                                                                                                                                                                  span
                                                                                                                                                                  end
                                                                                                                                                                  131
                                                                                                                                                                  end exclusive
                                                                                                                                                                  true
                                                                                                                                                                  exact text
                                                                                                                                                                  adult patients
                                                                                                                                                                  label id
                                                                                                                                                                  04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                  offset unit
                                                                                                                                                                  unicode_code_points
                                                                                                                                                                  source array index
                                                                                                                                                                  1
                                                                                                                                                                  source field
                                                                                                                                                                  indications_and_usage_exact
                                                                                                                                                                  source text sha256
                                                                                                                                                                  79e546a86a581105faf4e6a070d201795a61db0f641d00f790c1276d6bac893c
                                                                                                                                                                  start
                                                                                                                                                                  117
                                                                                                                                                                regulatory links
                                                                                                                                                                  schema version
                                                                                                                                                                  0.1.0
                                                                                                                                                                  source batch sha256
                                                                                                                                                                  0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                                                                  source defined aliases
                                                                                                                                                                    source span
                                                                                                                                                                    end
                                                                                                                                                                    132
                                                                                                                                                                    end exclusive
                                                                                                                                                                    true
                                                                                                                                                                    exact text
                                                                                                                                                                    1.6 Ulcerative Colitis HYRIMOZ is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients.
                                                                                                                                                                    label id
                                                                                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                    offset unit
                                                                                                                                                                    unicode_code_points
                                                                                                                                                                    source array index
                                                                                                                                                                    1
                                                                                                                                                                    source field
                                                                                                                                                                    indications_and_usage_exact
                                                                                                                                                                    source text sha256
                                                                                                                                                                    79e546a86a581105faf4e6a070d201795a61db0f641d00f790c1276d6bac893c
                                                                                                                                                                    start
                                                                                                                                                                    0
                                                                                                                                                                    source url
                                                                                                                                                                    https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                                                                    spl effective date
                                                                                                                                                                    2025-10-17
                                                                                                                                                                    spl set id
                                                                                                                                                                    3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                                                                    spl version
                                                                                                                                                                    7
                                                                                                                                                                    structured fields status
                                                                                                                                                                    not_extracted_no_values_inferred_from_mentions
                                                                                                                                                                    structured indication
                                                                                                                                                                    age
                                                                                                                                                                    Source null
                                                                                                                                                                    approval pathway
                                                                                                                                                                    Source null
                                                                                                                                                                    biomarker and test
                                                                                                                                                                    Source null
                                                                                                                                                                    disease stage
                                                                                                                                                                    Source null
                                                                                                                                                                    limitations
                                                                                                                                                                    Source null
                                                                                                                                                                    line
                                                                                                                                                                    Source null
                                                                                                                                                                    prior therapy
                                                                                                                                                                    Source null
                                                                                                                                                                    regimen
                                                                                                                                                                    Source null
                                                                                                                                                                    tumor histology
                                                                                                                                                                    Source null
                                                                                                                                                                    use intent
                                                                                                                                                                    non_oncology_or_unclear_candidate
                                                                                                                                                                    Passage 35 · limitation of use
                                                                                                                                                                    application numbers
                                                                                                                                                                    1. BLA761071
                                                                                                                                                                    brand names
                                                                                                                                                                    1. HYRIMOZ
                                                                                                                                                                    classification reasons
                                                                                                                                                                    1. negative_or_not_established_clause
                                                                                                                                                                    clinical review status
                                                                                                                                                                    pending
                                                                                                                                                                    content role
                                                                                                                                                                    limitation_of_use
                                                                                                                                                                    context span
                                                                                                                                                                    end
                                                                                                                                                                    324
                                                                                                                                                                    end exclusive
                                                                                                                                                                    true
                                                                                                                                                                    exact text
                                                                                                                                                                    1.6 Ulcerative Colitis HYRIMOZ is indicated for the treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: The effectiveness of adalimumab products has not been established in patients who have lost response to or were intolerant to TNF-blockers [see Clinical Studies (14.7) ] .
                                                                                                                                                                    label id
                                                                                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                    offset unit
                                                                                                                                                                    unicode_code_points
                                                                                                                                                                    source array index
                                                                                                                                                                    1
                                                                                                                                                                    source field
                                                                                                                                                                    indications_and_usage_exact
                                                                                                                                                                    source text sha256
                                                                                                                                                                    79e546a86a581105faf4e6a070d201795a61db0f641d00f790c1276d6bac893c
                                                                                                                                                                    start
                                                                                                                                                                    0
                                                                                                                                                                    current approval status
                                                                                                                                                                    not_reconciled
                                                                                                                                                                    duplicate text group
                                                                                                                                                                    dup-e99e298aeba9667e586c
                                                                                                                                                                    extraction review status
                                                                                                                                                                    automated_candidate_pending_source_review
                                                                                                                                                                    generic names
                                                                                                                                                                    1. ADALIMUMAB-ADAZ
                                                                                                                                                                    id
                                                                                                                                                                    ind-span-6250b919562005e446e5
                                                                                                                                                                    label id
                                                                                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                    positive predicate support span
                                                                                                                                                                    Source null
                                                                                                                                                                    qualifier mentions
                                                                                                                                                                      regulatory links
                                                                                                                                                                        schema version
                                                                                                                                                                        0.1.0
                                                                                                                                                                        source batch sha256
                                                                                                                                                                        0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                                                                        source defined aliases
                                                                                                                                                                          source span
                                                                                                                                                                          end
                                                                                                                                                                          324
                                                                                                                                                                          end exclusive
                                                                                                                                                                          true
                                                                                                                                                                          exact text
                                                                                                                                                                          Limitations of Use: The effectiveness of adalimumab products has not been established in patients who have lost response to or were intolerant to TNF-blockers [see Clinical Studies (14.7) ] .
                                                                                                                                                                          label id
                                                                                                                                                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                          offset unit
                                                                                                                                                                          unicode_code_points
                                                                                                                                                                          source array index
                                                                                                                                                                          1
                                                                                                                                                                          source field
                                                                                                                                                                          indications_and_usage_exact
                                                                                                                                                                          source text sha256
                                                                                                                                                                          79e546a86a581105faf4e6a070d201795a61db0f641d00f790c1276d6bac893c
                                                                                                                                                                          start
                                                                                                                                                                          133
                                                                                                                                                                          source url
                                                                                                                                                                          https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                                                                          spl effective date
                                                                                                                                                                          2025-10-17
                                                                                                                                                                          spl set id
                                                                                                                                                                          3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                                                                          spl version
                                                                                                                                                                          7
                                                                                                                                                                          structured fields status
                                                                                                                                                                          not_extracted_no_values_inferred_from_mentions
                                                                                                                                                                          structured indication
                                                                                                                                                                          age
                                                                                                                                                                          Source null
                                                                                                                                                                          approval pathway
                                                                                                                                                                          Source null
                                                                                                                                                                          biomarker and test
                                                                                                                                                                          Source null
                                                                                                                                                                          disease stage
                                                                                                                                                                          Source null
                                                                                                                                                                          limitations
                                                                                                                                                                          Source null
                                                                                                                                                                          line
                                                                                                                                                                          Source null
                                                                                                                                                                          prior therapy
                                                                                                                                                                          Source null
                                                                                                                                                                          regimen
                                                                                                                                                                          Source null
                                                                                                                                                                          tumor histology
                                                                                                                                                                          Source null
                                                                                                                                                                          use intent
                                                                                                                                                                          not_applicable
                                                                                                                                                                          Passage 36 · positive indication candidate
                                                                                                                                                                          application numbers
                                                                                                                                                                          1. BLA761071
                                                                                                                                                                          brand names
                                                                                                                                                                          1. HYRIMOZ
                                                                                                                                                                          classification reasons
                                                                                                                                                                          1. explicit_positive_indication_predicate
                                                                                                                                                                          2. no_tumor_directed_keyword_in_positive_statement
                                                                                                                                                                          clinical review status
                                                                                                                                                                          pending
                                                                                                                                                                          content role
                                                                                                                                                                          positive_indication_candidate
                                                                                                                                                                          context span
                                                                                                                                                                          end
                                                                                                                                                                          416
                                                                                                                                                                          end exclusive
                                                                                                                                                                          true
                                                                                                                                                                          exact text
                                                                                                                                                                          1.7 Plaque Psoriasis HYRIMOZ is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. HYRIMOZ should only be administered to patients who will be closely monitored and have regular follow-up visits with a physician [see Warnings and Precautions (5) ] .
                                                                                                                                                                          label id
                                                                                                                                                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                          offset unit
                                                                                                                                                                          unicode_code_points
                                                                                                                                                                          source array index
                                                                                                                                                                          2
                                                                                                                                                                          source field
                                                                                                                                                                          indications_and_usage_exact
                                                                                                                                                                          source text sha256
                                                                                                                                                                          57449ee73ee32650ca11e9092b0e10b2625308dc8ff1605d01f01ed558f68e7e
                                                                                                                                                                          start
                                                                                                                                                                          0
                                                                                                                                                                          current approval status
                                                                                                                                                                          not_reconciled
                                                                                                                                                                          duplicate text group
                                                                                                                                                                          dup-c878ad80c94005d8c69f
                                                                                                                                                                          extraction review status
                                                                                                                                                                          automated_candidate_pending_source_review
                                                                                                                                                                          generic names
                                                                                                                                                                          1. ADALIMUMAB-ADAZ
                                                                                                                                                                          id
                                                                                                                                                                          ind-span-1d8daa06351679bc2fec
                                                                                                                                                                          label id
                                                                                                                                                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                          positive predicate support span
                                                                                                                                                                          end
                                                                                                                                                                          41
                                                                                                                                                                          end exclusive
                                                                                                                                                                          true
                                                                                                                                                                          exact text
                                                                                                                                                                          is indicated
                                                                                                                                                                          label id
                                                                                                                                                                          04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                          offset unit
                                                                                                                                                                          unicode_code_points
                                                                                                                                                                          source array index
                                                                                                                                                                          2
                                                                                                                                                                          source field
                                                                                                                                                                          indications_and_usage_exact
                                                                                                                                                                          source text sha256
                                                                                                                                                                          57449ee73ee32650ca11e9092b0e10b2625308dc8ff1605d01f01ed558f68e7e
                                                                                                                                                                          start
                                                                                                                                                                          29
                                                                                                                                                                          qualifier mentions
                                                                                                                                                                          1. context exact
                                                                                                                                                                            Plaque Psoriasis HYRIMOZ is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are ca
                                                                                                                                                                            kind
                                                                                                                                                                            age
                                                                                                                                                                            polarity
                                                                                                                                                                            not_inferred
                                                                                                                                                                            span
                                                                                                                                                                            end
                                                                                                                                                                            77
                                                                                                                                                                            end exclusive
                                                                                                                                                                            true
                                                                                                                                                                            exact text
                                                                                                                                                                            adult patients
                                                                                                                                                                            label id
                                                                                                                                                                            04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                            offset unit
                                                                                                                                                                            unicode_code_points
                                                                                                                                                                            source array index
                                                                                                                                                                            2
                                                                                                                                                                            source field
                                                                                                                                                                            indications_and_usage_exact
                                                                                                                                                                            source text sha256
                                                                                                                                                                            57449ee73ee32650ca11e9092b0e10b2625308dc8ff1605d01f01ed558f68e7e
                                                                                                                                                                            start
                                                                                                                                                                            63
                                                                                                                                                                          regulatory links
                                                                                                                                                                            schema version
                                                                                                                                                                            0.1.0
                                                                                                                                                                            source batch sha256
                                                                                                                                                                            0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                                                                            source defined aliases
                                                                                                                                                                              source span
                                                                                                                                                                              end
                                                                                                                                                                              249
                                                                                                                                                                              end exclusive
                                                                                                                                                                              true
                                                                                                                                                                              exact text
                                                                                                                                                                              1.7 Plaque Psoriasis HYRIMOZ is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
                                                                                                                                                                              label id
                                                                                                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                              offset unit
                                                                                                                                                                              unicode_code_points
                                                                                                                                                                              source array index
                                                                                                                                                                              2
                                                                                                                                                                              source field
                                                                                                                                                                              indications_and_usage_exact
                                                                                                                                                                              source text sha256
                                                                                                                                                                              57449ee73ee32650ca11e9092b0e10b2625308dc8ff1605d01f01ed558f68e7e
                                                                                                                                                                              start
                                                                                                                                                                              0
                                                                                                                                                                              source url
                                                                                                                                                                              https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                                                                              spl effective date
                                                                                                                                                                              2025-10-17
                                                                                                                                                                              spl set id
                                                                                                                                                                              3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                                                                              spl version
                                                                                                                                                                              7
                                                                                                                                                                              structured fields status
                                                                                                                                                                              not_extracted_no_values_inferred_from_mentions
                                                                                                                                                                              structured indication
                                                                                                                                                                              age
                                                                                                                                                                              Source null
                                                                                                                                                                              approval pathway
                                                                                                                                                                              Source null
                                                                                                                                                                              biomarker and test
                                                                                                                                                                              Source null
                                                                                                                                                                              disease stage
                                                                                                                                                                              Source null
                                                                                                                                                                              limitations
                                                                                                                                                                              Source null
                                                                                                                                                                              line
                                                                                                                                                                              Source null
                                                                                                                                                                              prior therapy
                                                                                                                                                                              Source null
                                                                                                                                                                              regimen
                                                                                                                                                                              Source null
                                                                                                                                                                              tumor histology
                                                                                                                                                                              Source null
                                                                                                                                                                              use intent
                                                                                                                                                                              non_oncology_or_unclear_candidate
                                                                                                                                                                              Passage 37 · risk or warning
                                                                                                                                                                              application numbers
                                                                                                                                                                              1. BLA761071
                                                                                                                                                                              brand names
                                                                                                                                                                              1. HYRIMOZ
                                                                                                                                                                              classification reasons
                                                                                                                                                                              1. risk_or_warning_words_without_positive_predicate
                                                                                                                                                                              clinical review status
                                                                                                                                                                              pending
                                                                                                                                                                              content role
                                                                                                                                                                              risk_or_warning
                                                                                                                                                                              context span
                                                                                                                                                                              end
                                                                                                                                                                              416
                                                                                                                                                                              end exclusive
                                                                                                                                                                              true
                                                                                                                                                                              exact text
                                                                                                                                                                              treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. HYRIMOZ should only be administered to patients who will be closely monitored and have regular follow-up visits with a physician [see Warnings and Precautions (5) ] .
                                                                                                                                                                              label id
                                                                                                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                              offset unit
                                                                                                                                                                              unicode_code_points
                                                                                                                                                                              source array index
                                                                                                                                                                              2
                                                                                                                                                                              source field
                                                                                                                                                                              indications_and_usage_exact
                                                                                                                                                                              source text sha256
                                                                                                                                                                              57449ee73ee32650ca11e9092b0e10b2625308dc8ff1605d01f01ed558f68e7e
                                                                                                                                                                              start
                                                                                                                                                                              50
                                                                                                                                                                              current approval status
                                                                                                                                                                              not_reconciled
                                                                                                                                                                              duplicate text group
                                                                                                                                                                              dup-2d77db92632a9b459a6e
                                                                                                                                                                              extraction review status
                                                                                                                                                                              automated_candidate_pending_source_review
                                                                                                                                                                              generic names
                                                                                                                                                                              1. ADALIMUMAB-ADAZ
                                                                                                                                                                              id
                                                                                                                                                                              ind-span-c2be858238fc879bc79b
                                                                                                                                                                              label id
                                                                                                                                                                              04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                              positive predicate support span
                                                                                                                                                                              Source null
                                                                                                                                                                              qualifier mentions
                                                                                                                                                                                regulatory links
                                                                                                                                                                                  schema version
                                                                                                                                                                                  0.1.0
                                                                                                                                                                                  source batch sha256
                                                                                                                                                                                  0dba7a040bbbf460aa9f482c5b67c9f28f75fc9df775ee1e7b345b758f780e07
                                                                                                                                                                                  source defined aliases
                                                                                                                                                                                    source span
                                                                                                                                                                                    end
                                                                                                                                                                                    416
                                                                                                                                                                                    end exclusive
                                                                                                                                                                                    true
                                                                                                                                                                                    exact text
                                                                                                                                                                                    HYRIMOZ should only be administered to patients who will be closely monitored and have regular follow-up visits with a physician [see Warnings and Precautions (5) ] .
                                                                                                                                                                                    label id
                                                                                                                                                                                    04bedd16-44e8-4761-bb65-d4678c4013af
                                                                                                                                                                                    offset unit
                                                                                                                                                                                    unicode_code_points
                                                                                                                                                                                    source array index
                                                                                                                                                                                    2
                                                                                                                                                                                    source field
                                                                                                                                                                                    indications_and_usage_exact
                                                                                                                                                                                    source text sha256
                                                                                                                                                                                    57449ee73ee32650ca11e9092b0e10b2625308dc8ff1605d01f01ed558f68e7e
                                                                                                                                                                                    start
                                                                                                                                                                                    250
                                                                                                                                                                                    source url
                                                                                                                                                                                    https://api.fda.gov/drug/label.json?search=id%3A%2204bedd16-44e8-4761-bb65-d4678c4013af%22
                                                                                                                                                                                    spl effective date
                                                                                                                                                                                    2025-10-17
                                                                                                                                                                                    spl set id
                                                                                                                                                                                    3e303a4a-980b-4f2a-9d03-786928758637
                                                                                                                                                                                    spl version
                                                                                                                                                                                    7
                                                                                                                                                                                    structured fields status
                                                                                                                                                                                    not_extracted_no_values_inferred_from_mentions
                                                                                                                                                                                    structured indication
                                                                                                                                                                                    age
                                                                                                                                                                                    Source null
                                                                                                                                                                                    approval pathway
                                                                                                                                                                                    Source null
                                                                                                                                                                                    biomarker and test
                                                                                                                                                                                    Source null
                                                                                                                                                                                    disease stage
                                                                                                                                                                                    Source null
                                                                                                                                                                                    limitations
                                                                                                                                                                                    Source null
                                                                                                                                                                                    line
                                                                                                                                                                                    Source null
                                                                                                                                                                                    prior therapy
                                                                                                                                                                                    Source null
                                                                                                                                                                                    regimen
                                                                                                                                                                                    Source null
                                                                                                                                                                                    tumor histology
                                                                                                                                                                                    Source null
                                                                                                                                                                                    use intent
                                                                                                                                                                                    not_applicable

                                                                                                                                                                                    Preserved source evidence · Not medical advice